Prescription ID | TCMF5126 |
Pinyin Name | Qiang Li Jian Shen Jiao Nang |
Chinese Name | 强力健身胶囊 |
English Name | Qiang Li Jian Shen Capsules |
Function Description | 眩晕, 不寐, 健忘, 腰痛 |
Indications | Lumbago disorder, Vertigo disorder, Forgetfulness disorder, Insomnia disorder, Insomnia, Dizziness, Lumbago |
Disease ICD-11 Category |
SC61 [Lumbago disorder (TM1), 腰痛 (TM1)
]; SD22 [Vertigo disorder (TM1), 眩晕 (TM1) ]; SD23 [Forgetfulness disorder (TM1), 健忘 (TM1) ]; SD84 [Insomnia disorder (TM1), 不寐 (TM1) ]; 7A0Z [Insomnia disorders, unspecified, 失眠障碍,未特指的 ]; MB48 [Dizziness and giddiness, 头晕和眩晕 ]; ME84.2Z [Low back pain, unspecified, 下腰痛,未特指的 ]; |
Human Tissues Associated with Indication | Brain, Heart |
Reference | CFDA |
Reference Book/link | http://samr.cfda.gov.cn/WS01/CL0001/ |
Component ID | Latin Name | Chinese Name | Component Quantity | Barcode |
---|---|---|---|---|
TCMH1036 | Spatholobus suberectus | 鸡血藤 | TCMH1036 | ITSAK2607-14 |
TCMH967 | Polygonatum sibiricum | 黄精 | TCMH967 | ITSAH4762-14 |
TCMH1133 | Rosa laevigata | 金樱子 | TCMH1133 | ITSAJ4477-14 |
TCMH1565 | Millettia speciosa champ | 牛大力 | TCMH1565 | |
TCMH1597 | Ligustrum lucidum | 女贞子 | TCMH1597 | ITSAM2109-14 |
TCMH1019 | NA | 鸡睾丸 | TCMH1019 | |
TCMH2149 | Cuscuta australis | 菟丝子 | TCMH2149 | ITSAP4209-14 |
TCMH628 | Glycyrrhiza uralensis | 甘草 | TCMH628 | ITSAM892-14 |
TCMH2554 | Polygala tenuifolia | 远志 | TCMH2554 | MF096619 |
TCMH522 | Vanilla planifolia | 独脚球 | TCMH522 | GBVC1314-11, GBVC1313-11 |
TCMH1740 | Cistanche deserticola | 肉苁蓉 | TCMH1740 | ITSAM2511-14 |
TCMH843 | radix kadsurae coccineae | 黑老虎根 | TCMH843 | |
TCMH1966 | Rehmannia glutinosa | 熟地黄 | TCMH1966 | ITSAH4578-14 |
TCMH2507 | Epimedium brevicornum | 淫羊藿 | TCMH2507 | AY362429 |
TCMH197 | Bombyx mori | 蚕蛾 | TCMH197 | AGIRI001-17 |
Target ID | Gene Symbol | Target Name | Target Class | Uniprot ID |
---|---|---|---|---|
TCMT101 | PTPN1 | Protein-tyrosine phosphatase 1B | Hydrolase | P18031 |
TCMT102 | ACP1 | Low molecular weight phosphotyrosine protein phosphatase | Hydrolase | P24666 |
TCMT103 | PTPRF | Receptor-type tyrosine-protein phosphatase F (LAR) | Hydrolase | P10586 |
TCMT107 | GRIK2 | Glutamate receptor ionotropic kainate 2 | Ion channel | Q13002 |
TCMT109 | GRIA2 | Glutamate receptor ionotropic, AMPA 2 | Ion channel | P42262 |
TCMT110 | GRIA4 | Glutamate receptor ionotropic, AMPA 4 | Ion channel | P48058 |
TCMT111 | GRIK5 | Glutamate receptor ionotropic kainate 5 | Ion channel | Q16478 |
TCMT112 | ADORA3 | Adenosine A3 receptor | GPCR | P0DMS8 |
TCMT118 | MGAM | Maltase-glucoamylase | Hydrolase | O43451 |
TCMT127 | PARP1 | Poly [ADP-ribose] polymerase-1 | Transferase | P09874 |
TCMT128 | TNKS2 | Tankyrase-2 | Transferase | Q9H2K2 |
TCMT129 | TNKS | Tankyrase-1 | Transferase | O95271 |
TCMT130 | ALOX5 | Arachidonate 5-lipoxygenase | Oxidoreductase | P09917 |
TCMT131 | ACHE | Acetylcholinesterase | Hydrolase | P22303 |
TCMT133 | CA1 | Carbonic anhydrase I | Lyase | P00915 |
TCMT134 | CA2 | Carbonic anhydrase II | Lyase | P00918 |
TCMT135 | CA14 | Carbonic anhydrase XIV | Lyase | Q9ULX7 |
TCMT136 | CA12 | Carbonic anhydrase XII | Lyase | O43570 |
TCMT137 | CA9 | Carbonic anhydrase IX | Lyase | Q16790 |
TCMT138 | CA7 | Carbonic anhydrase VII | Lyase | P43166 |
TCMT142 | CA4 | Carbonic anhydrase IV | Lyase | P22748 |
TCMT150 | RORC | Nuclear receptor ROR-gamma | Nuclear receptor | P51449 |
TCMT156 | CYP19A1 | Cytochrome P450 19A1 | Oxidoreductase | P11511 |
TCMT159 | TYR | Tyrosinase | Oxidoreductase | P14679 |
TCMT162 | UGT1A1 | UDP-glucuronosyltransferase 1-1 | Transferase | P22309 |
TCMT174 | HSD11B1 | 11-beta-hydroxysteroid dehydrogenase 1 | Oxidoreductase | P28845 |
TCMT18 | GAA | Lysosomal alpha-glucosidase | Hydrolase | P10253 |
TCMT189 | DUSP3 | Dual specificity protein phosphatase 3 | Hydrolase | P51452 |
TCMT190 | PTPN2 | T-cell protein-tyrosine phosphatase | Hydrolase | P17706 |
TCMT209 | HSD11B2 | 11-beta-hydroxysteroid dehydrogenase 2 | Oxidoreductase | P80365 |
TCMT212 | SRC | Tyrosine-protein kinase SRC | Kinase | P12931 |
TCMT215 | CYP1A1 | Cytochrome P450 1A1 | Oxidoreductase | P04798 |
TCMT217 | CYP2C8 | Cytochrome P450 2C8 | Oxidoreductase | P10632 |
TCMT219 | CYP1A2 | Cytochrome P450 1A2 | Oxidoreductase | P05177 |
TCMT223 | AKR1B1 | Aldose reductase | Oxidoreductase | P15121 |
TCMT23 | ALPL | Alkaline phosphatase, tissue-nonspecific isozyme | Hydrolase | P05186 |
TCMT231 | GBA2 | Beta-glucosidase | Hydrolase | Q9HCG7 |
TCMT236 | ESR2 | Estrogen receptor beta | Nuclear receptor | Q92731 |
TCMT239 | PIM1 | Serine/threonine-protein kinase PIM1 | Kinase | P11309 |
TCMT241 | CHRNA7 | Neuronal acetylcholine receptor protein alpha-7 subunit | Ion channel | P36544 |
TCMT249 | CDK6 | Cyclin-dependent kinase 6 | Kinase | Q00534 |
TCMT254 | CBR1 | Carbonyl reductase [NADPH] 1 | Oxidoreductase | P16152 |
TCMT257 | CYP1B1 | Cytochrome P450 1B1 | Oxidoreductase | Q16678 |
TCMT260 | FLT3 | Tyrosine-protein kinase receptor FLT3 | Kinase | P36888 |
TCMT261 | DAPK1 | Death-associated protein kinase 1 | Kinase | P53355 |
TCMT280 | AKR1B10 | Aldo-keto reductase family 1 member B10 | Oxidoreductase | O60218 |
TCMT296 | ADORA1 | Adenosine A1 receptor | GPCR | P30542 |
TCMT297 | FABP4 | Fatty acid binding protein adipocyte | Unclassified | P15090 |
TCMT298 | FABP3 | Fatty acid binding protein muscle | Hydrolase | P05413 |
TCMT302 | HMGCR | HMG-CoA reductase | Oxidoreductase | P04035 |
TCMT322 | MMP13 | Matrix metalloproteinase 13 | Hydrolase | P45452 |
TCMT344 | AOX1 | Aldehyde oxidase | Oxidoreductase | Q06278 |
TCMT354 | AURKA | Serine/threonine-protein kinase Aurora-A | Kinase | O14965 |
TCMT369 | IGF1R | Insulin-like growth factor I receptor | Kinase | P08069 |
TCMT370 | KDR | Vascular endothelial growth factor receptor 2 | Kinase | P35968 |
TCMT374 | AURKB | Serine/threonine-protein kinase Aurora-B | Kinase | Q96GD4 |
TCMT377 | INSR | Insulin receptor | Kinase | P06213 |
TCMT388 | AXL | Tyrosine-protein kinase receptor UFO | Kinase | P30530 |
TCMT401 | MET | Hepatocyte growth factor receptor | Kinase | P08581 |
TCMT418 | EPHB4 | Ephrin type-B receptor 4 | Kinase | P54760 |
TCMT422 | CAMK2B | CaM kinase II beta | Kinase | Q13554 |
TCMT423 | EGFR | Epidermal growth factor receptor erbB1 | Kinase | P00533 |
TCMT436 | NUAK1 | NUAK family SNF1-like kinase 1 | Kinase | O60285 |
TCMT445 | NEK2 | Serine/threonine-protein kinase NEK2 | Kinase | P51955 |
TCMT45 | APP | Beta amyloid A4 protein | Unclassified | P05067 |
TCMT457 | FLT4 | Vascular endothelial growth factor receptor 3 | Kinase | P35916 |
TCMT46 | F3 | Coagulation factor III | Unclassified | P13726 |
TCMT462 | NEK6 | Serine/threonine-protein kinase NEK6 | Kinase | Q9HC98 |
TCMT47 | BCL2 | Apoptosis regulator Bcl-2 | Ion channel | P10415 |
TCMT479 | AKT1 | Serine/threonine-protein kinase AKT | Kinase | P31749 |
TCMT484 | PLK1 | Serine/threonine-protein kinase PLK1 | Kinase | P53350 |
TCMT502 | TEK | Tyrosine-protein kinase TIE-2 | Kinase | Q02763 |
TCMT506 | PTK2B | Protein tyrosine kinase 2 beta | Kinase | Q14289 |
TCMT536 | PDGFRB | Platelet-derived growth factor receptor beta | Kinase | P09619 |
TCMT552 | CHRNA3 | Neuronal acetylcholine receptor subunit alpha-3 | Ion channel | P32297 |
TCMT563 | CDC25B | Dual specificity phosphatase Cdc25B | Hydrolase | P30305 |
TCMT591 | ESRRA | Estrogen-related receptor alpha | Nuclear receptor | P11474 |
TCMT592 | XDH | Xanthine dehydrogenase | Oxidoreductase | P47989 |
TCMT597 | SLC28A3 | Solute carrier family 28 member 3 | Transporter | Q9HAS3 |
TCMT605 | EDNRA | Endothelin receptor ET-A | GPCR | P25101 |
TCMT614 | EGLN1 | Egl nine homolog 1 | Oxidoreductase | Q9GZT9 |
TCMT626 | BRAF | Serine/threonine-protein kinase B-raf | Kinase | P15056 |
TCMT63 | PPARA | Peroxisome proliferator-activated receptor alpha | Nuclear receptor | Q07869 |
TCMT637 | SIRT3 | NAD-dependent deacetylase sirtuin 3 | Hydrolase | Q9NTG7 |
TCMT638 | SIRT2 | NAD-dependent deacetylase sirtuin 2 | Hydrolase | Q8IXJ6 |
TCMT65 | HSD17B1 | Estradiol 17-beta-dehydrogenase 1 | Oxidoreductase | P14061 |
TCMT653 | GRM1 | Metabotropic glutamate receptor 1 | GPCR | Q13255 |
TCMT654 | GRM5 | Metabotropic glutamate receptor 5 | GPCR | P41594 |
TCMT655 | GRM2 | Metabotropic glutamate receptor 2 | GPCR | Q14416 |
TCMT656 | GRM3 | Metabotropic glutamate receptor 3 | GPCR | Q14832 |
TCMT657 | GRM4 | Metabotropic glutamate receptor 4 | GPCR | Q14833 |
TCMT66 | HSD17B2 | Estradiol 17-beta-dehydrogenase 2 | Oxidoreductase | P37059 |
TCMT660 | GRM8 | Metabotropic glutamate receptor 8 | GPCR | O00222 |
TCMT664 | SLC1A1 | Excitatory amino acid transporter 3 | Transporter | P43005 |
TCMT709 | SLC28A2 | Sodium/nucleoside cotransporter 2 | Transporter | O43868 |
TCMT710 | SLC28A1 | Sodium/nucleoside cotransporter 1 | Transporter | O00337 |
TCMT721 | HSPA1A | Heat shock 70 kDa protein 1 | Unclassified | P0DMV8 |
TCMT739 | GPR35 | G-protein coupled receptor 35 | GPCR | Q9HC97 |
TCMT752 | CSNK2A1 | Casein kinase II alpha | Kinase | P68400 |
TCMT753 | SMAD3 | Mothers against decapentaplegic homolog 3 | Unclassified | P84022 |
TCMT755 | PLK4 | Serine/threonine-protein kinase PLK4 | Kinase | O00444 |
TCMT756 | MAP3K8 | Mitogen-activated protein kinase kinase kinase 8 | Kinase | P41279 |
TCMT784 | AVPR2 | Vasopressin V2 receptor | GPCR | P30518 |
TCMT785 | CXCR1 | Interleukin-8 receptor A | GPCR | P25024 |
TCMT786 | CCR4 | C-C chemokine receptor type 4 | GPCR | P51679 |
TCMT791 | PKN1 | Protein kinase N1 | Kinase | Q16512 |
TCMT793 | PYGL | Liver glycogen phosphorylase | Transferase | P06737 |
TCMT808 | FABP5 | Fatty acid binding protein epidermal | Unclassified | Q01469 |
TCMT809 | FABP2 | Fatty acid binding protein intestinal | Unclassified | P12104 |
TCMT810 | TLR2 | Toll-like receptor 2 | Unclassified | O60603 |
TCMT82 | ESR1 | Estrogen receptor alpha | Nuclear receptor | P03372 |
TCMT822 | FUT7 | Alpha-(1,3)-fucosyltransferase 7 | Transferase | Q11130 |
TCMT87 | CYP2C9 | Cytochrome P450 2C9 | Oxidoreductase | P11712 |
TCMT899 | ALDH2 | Aldehyde dehydrogenase | Oxidoreductase | P05091 |
TCMT910 | ESRRB | Estrogen-related receptor beta | Nuclear receptor | O95718 |
Target ID | Target Name |
---|---|
TCMT1170 | Enterobacter cloacae |
TCMT1175 | Human immunodeficiency virus |
TCMT1176 | Streptococcus pneumoniae |
TCMT1178 | Actinomyces viscosus |
TCMT1179 | Escherichia coli ATCC 8739 |
TCMT1180 | Human herpesvirus 2 |
TCMT1181 | Mycobacterium tuberculosis H37Ra |
TCMT1186 | Plasmodium yoelii yoelii |
TCMT1189 | Pseudomonas fluorescens |
TCMT1190 | Plasmodium falciparum (isolate FcB1 / Columbia) |
TCMT1191 | Bacillus megaterium |
TCMT1207 | Legionella pneumophila |
TCMT1208 | Escherichia coli K12 |
TCMT1209 | Staphylococcus haemolyticus |
TCMT1212 | Verticillium dahliae |
TCMT1214 | Enterococcus faecium |
TCMT1215 | Pseudomonas aeruginosa PAO1 |
TCMT1217 | Bacillus anthracis |
TCMT1218 | Staphylococcus aureus |
TCMT1221 | Human herpesvirus 4 |
TCMT1222 | Plasmodium falciparum D6 |
TCMT1223 | Staphylococcus epidermidis |
TCMT1224 | Proteus mirabilis |
TCMT1226 | Klebsiella pneumoniae |
TCMT1227 | Streptococcus |
TCMT1229 | Enterococcus faecalis |
TCMT1231 | Human herpesvirus 1 strain KOS |
TCMT1232 | Pseudomonas aeruginosa |
TCMT1234 | Bacillus coagulans |
TCMT1235 | Clostridium sporogenes |
TCMT1236 | Mycobacterium bovis |
TCMT1237 | Mycobacterium kansasii |
TCMT1238 | Mycobacterium xenopi |
TCMT1239 | Mycobacterium marinum |
TCMT1243 | Aspergillus flavus |
TCMT1245 | Phytophthora cactorum |
TCMT1246 | Escherichia coli |
TCMT1247 | Human herpesvirus 1 |
TCMT1248 | Hepatitis C virus |
TCMT1249 | Dengue virus 2 |
TCMT1251 | Candida albicans |
TCMT1253 | Penicillium chrysogenum |
TCMT1255 | Human immunodeficiency virus 1 |
TCMT1260 | Streptococcus agalactiae |
TCMT1282 | Colletotrichum orbiculare |
TCMT1284 | Penicillium expansum |
TCMT1286 | Bacillus cereus |
TCMT1294 | Human parainfluenza virus 3 |
TCMT1319 | Corynebacterium xerosis |
TCMT1322 | Streptococcus mitis |
TCMT1323 | Corynebacterium pseudodiphtheriticum |
TCMT1324 | Corynebacterium diphtheriae |
TCMT1346 | Helicobacter pylori |
TCMT1349 | Helicobacter pylori SS1 |
TCMT1361 | Neisseria meningitidis |
TCMT1382 | Plasmodium falciparum (isolate K1 / Thailand) |
TCMT1390 | Human herpesvirus 2 strain G |
TCMT1408 | Colletotrichum gloeosporioides |
TCMT1410 | Listeria monocytogenes |
TCMT1412 | Salmonella typhimurium |
TCMT1438 | Plasmodium falciparum |
TCMT1439 | Mycobacterium smegmatis |
TCMT1442 | Leishmania donovani |
TCMT1443 | Leishmania amazonensis |
TCMT1447 | Respiratory syncytial virus |
TCMT1448 | Enterobacter aerogenes |
TCMT1449 | Influenza A virus |
TCMT1450 | Plasmodium falciparum 3D7 |
TCMT1454 | Bacillus subtilis |
TCMT1455 | Mycobacterium tuberculosis H37Rv |
TCMT1457 | Leishmania major |
TCMT1458 | Filobasidiella neoformans |
TCMT1462 | Streptococcus mutans |
TCMT1463 | Mycobacterium tuberculosis |
TCMT1464 | Hepatitis B virus |
TCMT1465 | Entamoeba histolytica |
GO Term | GO Name | Enriched Genes | Log10 Adjusted P-value |
---|---|---|---|
[BP] GO:0065008 | regulation of biological quality | ACHE, ADORA1, AKR1B1, APP, AURKB, AXL, BCL2, CA12, CA2, CA7, CDK6, CHRNA3, CHRNA7, CYP19A1, CYP1A1, CYP1B1, EDNRA, EGFR, ESR1, F3, FABP3, FABP4, FLT3, GAA, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM5, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSPA1A, INSR, KDR, MET, PPARA, SLC1A1, SMAD3, SRC, TEK, TNKS, TNKS2, XDH | 12.9251 |
[BP] GO:0010033 | response to organic substance | AKR1B1, ALPL, APP, AXL, BCL2, CA2, CA9, CDK6, CHRNA3, CHRNA7, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, EGFR, ESR1, ESRRA, FABP3, FABP4, FLT3, GRIK5, GRM5, HMGCR, HSD11B2, HSD17B2, HSPA1A, IGF1R, INSR, KDR, PPARA, RORC, SMAD3, SRC, TEK, TYR | 10.8205 |
[BP] GO:1901700 | response to oxygen-containing compound | AKR1B1, ALPL, APP, AXL, BCL2, CA9, CDK6, CHRNA3, CHRNA7, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, EGFR, ESR1, ESRRA, FABP3, GRIK5, GRM5, HMGCR, HSD11B2, HSD17B2, IGF1R, INSR, PPARA, RORC, SRC, TEK, TYR | 10.8205 |
[BP] GO:0008202 | steroid metabolic process | AKR1B1, AKR1B10, APP, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, GBA2, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2 | 8.6991 |
[BP] GO:0042221 | response to chemical | AKR1B1, ALPL, APP, AXL, BCL2, CA2, CA9, CDK6, CHRNA3, CHRNA7, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, EGFR, ESR1, ESRRA, FABP3, FABP4, FLT3, GRIK5, GRM5, HMGCR, HSD11B2, HSD17B2, HSPA1A, IGF1R, INSR, KDR, PPARA, RORC, SMAD3, SRC, TEK, TYR | 8.49085 |
[BP] GO:0009719 | response to endogenous stimulus | AKR1B1, ALPL, APP, BCL2, CA2, CA9, CHRNA3, CHRNA7, CSNK2A1, CYP1A2, EGFR, ESR1, ESRRA, FABP3, FLT3, GRM5, HSD11B2, IGF1R, INSR, PPARA, SMAD3, SRC, TEK | 8.3963 |
[BP] GO:0006629 | lipid metabolic process | ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, APP, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, EGFR, ESR1, FABP3, FABP4, FUT7, GBA2, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2, MET, PPARA | 8.37375 |
[BP] GO:0010646 | regulation of cell communication | ACHE, ADORA1, AKR1B1, APP, AURKB, AXL, BCL2, CA2, CA7, CHRNA3, CHRNA7, CSNK2A1, CYP19A1, CYP1B1, DUSP3, EGFR, ESR1, ESR2, F3, FLT3, GPR35, GRIK5, GRM1, GRM3, GRM5, GRM8, HMGCR, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, XDH | 8.29002 |
[BP] GO:0023051 | regulation of signaling | ACHE, ADORA1, AKR1B1, APP, AURKB, AXL, BCL2, CA2, CA7, CHRNA3, CHRNA7, CSNK2A1, CYP19A1, CYP1B1, DUSP3, EGFR, ESR1, ESR2, F3, FLT3, GPR35, GRIK5, GRM1, GRM3, GRM5, GRM8, HMGCR, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, XDH | 8.14641 |
[BP] GO:0007215 | None | APP, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8 | 8.09871 |
[BP] GO:0009725 | response to hormone | AKR1B1, ALPL, BCL2, CA2, CA9, CHRNA3, CHRNA7, CSNK2A1, CYP1A2, EGFR, ESR1, ESRRA, FABP3, FLT3, HSD11B2, INSR, PPARA, SRC, TEK | 8.09849 |
[BP] GO:0010647 | positive regulation of cell communication | ADORA1, AKR1B1, APP, AXL, BCL2, CA2, CA7, CHRNA7, CSNK2A1, CYP19A1, CYP1B1, EGFR, F3, FLT3, GPR35, GRM1, HMGCR, HSPA1A, INSR, KDR, MET, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, XDH | 8.01352 |
[BP] GO:0023056 | positive regulation of signaling | ADORA1, AKR1B1, APP, AXL, BCL2, CA2, CA7, CHRNA7, CSNK2A1, CYP19A1, CYP1B1, EGFR, F3, FLT3, GPR35, GRM1, HMGCR, HSPA1A, INSR, KDR, MET, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, XDH | 8.013 |
[BP] GO:0019220 | regulation of phosphate metabolic process | ADORA1, APP, BCL2, CDC25B, CHRNA3, CHRNA7, DUSP3, EDNRA, EGFR, ESRRB, FABP3, FABP4, FLT3, GRM1, GRM3, GRM5, GRM8, HMGCR, IGF1R, INSR, KDR, NUAK1, PPARA, PTPN1, SMAD3, SRC, TEK, XDH | 7.53207 |
[BP] GO:0033993 | response to lipid | ALPL, AXL, BCL2, CA2, CA9, CDK6, CSNK2A1, CYP1A1, CYP1A2, EGFR, ESR1, ESRRA, FABP3, FLT3, HSD11B2, HSD17B2, RORC, SRC, TYR | 7.53207 |
[BP] GO:0051174 | regulation of phosphorus metabolic process | ADORA1, APP, BCL2, CDC25B, CHRNA3, CHRNA7, DUSP3, EDNRA, EGFR, ESRRB, FABP3, FABP4, FLT3, GRM1, GRM3, GRM5, GRM8, HMGCR, IGF1R, INSR, KDR, NUAK1, PPARA, PTPN1, SMAD3, SRC, TEK, XDH | 7.47936 |
[BP] GO:0032501 | multicellular organismal process | ADORA1, AKR1B1, AKR1B10, ALOX5, ALPL, APP, AXL, BCL2, CHRNA3, CHRNA7, CYP19A1, CYP1A2, CYP1B1, DUSP3, EDNRA, EGFR, ESR1, ESRRB, F3, FABP4, GAA, GRM1, GRM5, GRM8, HMGCR, HSD11B2, HSD17B2, IGF1R, INSR, MET, MGAM, PIM1, PPARA, RORC, SMAD3, SRC, TEK, TNKS2, TYR | 7.47936 |
[BP] GO:0042127 | regulation of cell proliferation | ADORA1, ADORA3, AKR1B1, APP, BCL2, CDC25B, CDK6, CHRNA7, CSNK2A1, CYP1B1, EGFR, ESR1, ESRRA, F3, FABP3, FLT3, HMGCR, HSPA1A, IGF1R, INSR, KDR, NUAK1, PIM1, SMAD3, SRC, TEK, XDH | 7.42517 |
[BP] GO:0048513 | animal organ development | ACHE, AXL, BCL2, CA2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, EDNRA, EGFR, ESR1, ESRRA, ESRRB, FLT3, HSD11B1, HSD17B2, INSR, KDR, PPARA, SMAD3, SRC, TEK, TYR | 7.1592 |
[BP] GO:1902533 | positive regulation of intracellular signal transduction | ADORA1, AKR1B1, APP, AXL, BCL2, CHRNA7, CYP1B1, EGFR, F3, FLT3, GPR35, GRM1, HMGCR, HSPA1A, INSR, KDR, MET, PTPN1, SRC, TEK, XDH | 7.09049 |
[BP] GO:0044281 | small molecule metabolic process | AKR1B1, AKR1B10, ALDH2, ALOX5, AOX1, APP, CA1, CA12, CA2, CA4, CA7, CA9, CBR1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, FABP3, FUT7, GAA, GBA2, HMGCR, HSPA1A, PIM1, PPARA, TYR, XDH | 7.01411 |
[BP] GO:0050804 | modulation of chemical synaptic transmission | ACHE, ADORA1, APP, CA2, CA7, CHRNA3, CHRNA7, EGFR, GRIK5, GRM1, GRM3, GRM5, GRM8 | 6.98598 |
[BP] GO:0099177 | regulation of trans-synaptic signaling | ACHE, ADORA1, APP, CA2, CA7, CHRNA3, CHRNA7, EGFR, GRIK5, GRM1, GRM3, GRM5, GRM8 | 6.98598 |
[BP] GO:0032502 | developmental process | ACHE, ADORA1, AKR1B1, ALPL, APP, AURKB, AXL, BCL2, CA2, CA9, CBR1, CDC25B, CDK6, CHRNA3, CHRNA7, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DUSP3, EDNRA, EGFR, ESR1, ESRRA, ESRRB, FABP4, FLT3, FUT7, GAA, GBA2, HMGCR, HSD11B1, HSD17B2, INSR, KDR, MET, PIM1, PPARA, RORC, SMAD3, SRC, TEK, TNKS2, TYR | 6.91951 |
[BP] GO:0042592 | homeostatic process | ADORA1, AKR1B1, APP, AXL, BCL2, CA12, CA2, CA7, CHRNA7, EDNRA, EGFR, ESR1, FABP3, FABP4, FLT3, GAA, GPR35, GRIK5, GRM1, GRM5, INSR, MET, SMAD3, SRC | 6.89398 |
[BP] GO:0014070 | response to organic cyclic compound | ALPL, APP, BCL2, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, EGFR, ESR1, ESRRA, FLT3, HSD11B2, RORC, SRC, TEK, TYR | 6.75045 |
[BP] GO:0009967 | positive regulation of signal transduction | ADORA1, AKR1B1, APP, AXL, BCL2, CHRNA7, CSNK2A1, CYP1B1, EGFR, F3, FLT3, GPR35, GRM1, HMGCR, HSPA1A, INSR, KDR, MET, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, XDH | 6.75045 |
[BP] GO:0048522 | positive regulation of cellular process | ACHE, ADORA1, AKR1B1, APP, AURKB, AXL, BCL2, CA2, CA7, CDC25B, CDK6, CHRNA3, CHRNA7, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FLT3, GPR35, GRIK5, GRM1, GRM5, HMGCR, HSPA1A, IGF1R, INSR, KDR, MET, PIM1, PPARA, PTPN1, RORC, SMAD3, SRC, TEK, TNKS, TNKS2, XDH | 6.75045 |
[BP] GO:0015701 | bicarbonate transport | CA1, CA12, CA14, CA2, CA4, CA7, CA9 | 6.67882 |
[BP] GO:1902531 | regulation of intracellular signal transduction | ADORA1, AKR1B1, APP, AURKB, AXL, BCL2, CHRNA7, CSNK2A1, CYP1B1, DUSP3, EGFR, ESR1, F3, FLT3, GPR35, GRM1, HMGCR, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PTPN1, SRC, TEK, XDH | 6.57784 |
[BP] GO:0050790 | regulation of catalytic activity | ADORA1, ADORA3, APP, AURKB, BCL2, CDC25B, CHRNA3, CHRNA7, CSNK2A1, DUSP3, EDNRA, EGFR, ESR1, F3, FABP4, FLT3, GRM1, GRM3, GRM5, HMGCR, HSPA1A, IGF1R, INSR, NUAK1, PTPN1, SMAD3, SRC, TEK, TNKS, XDH | 6.39149 |
[BP] GO:0048518 | positive regulation of biological process | ACHE, ADORA1, AKR1B1, APP, AURKB, AXL, BCL2, CA2, CA7, CDC25B, CDK6, CHRNA3, CHRNA7, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, GPR35, GRIK5, GRM1, GRM5, HMGCR, HSPA1A, IGF1R, INSR, KDR, MET, PIM1, PPARA, PTPN1, RORC, SLC1A1, SMAD3, SRC, TEK, TNKS, TNKS2, XDH | 6.35097 |
[BP] GO:0019748 | secondary metabolic process | AKR1B1, AKR1B10, BCL2, CYP1A1, CYP1A2, CYP1B1, TYR | 6.27985 |
[BP] GO:0010941 | regulation of cell death | ADORA1, AKR1B1, AURKB, AXL, BCL2, CHRNA7, CSNK2A1, CYP1B1, EGFR, ESR1, F3, FLT3, GRIK5, HMGCR, HSPA1A, IGF1R, KDR, MET, PIM1, PPARA, PTPN1, SMAD3, SRC, TEK, XDH | 6.1545 |
[BP] GO:0065009 | regulation of molecular function | ADORA1, ADORA3, APP, AURKB, BCL2, CDC25B, CHRNA3, CHRNA7, CSNK2A1, CYP1B1, DUSP3, EDNRA, EGFR, ESR1, ESR2, F3, FABP4, FLT3, GPR35, GRM1, GRM3, GRM5, HMGCR, HSPA1A, IGF1R, INSR, MET, NUAK1, PIM1, PPARA, PTPN1, SMAD3, SRC, TEK, TNKS, XDH | 6.1545 |
[BP] GO:0048856 | anatomical structure development | ACHE, ADORA1, AKR1B1, ALPL, APP, AXL, BCL2, CA2, CDK6, CHRNA3, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DUSP3, EDNRA, EGFR, ESR1, ESRRA, ESRRB, FLT3, GAA, GBA2, HSD11B1, HSD17B2, INSR, KDR, PIM1, PPARA, RORC, SMAD3, SRC, TEK, TYR | 6.0497 |
[BP] GO:0042445 | hormone metabolic process | ACHE, AKR1B1, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD11B1, HSD11B2, HSD17B1, HSD17B2 | 5.94558 |
[BP] GO:0048878 | chemical homeostasis | AKR1B1, APP, BCL2, CA12, CA2, CA7, CHRNA7, EDNRA, EGFR, ESR1, FABP3, FABP4, GPR35, GRIK5, GRM1, GRM5, INSR, MET, SMAD3 | 5.93158 |
[BP] GO:0007165 | signal transduction | ADORA1, ADORA3, AKR1B1, APP, AXL, BCL2, CA1, CA2, CDK6, CHRNA3, CHRNA7, CSNK2A1, CYP1B1, EDNRA, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, IGF1R, INSR, KDR, MET, NUAK1, PIM1, PPARA, PTPN1, RORC, SMAD3, SRC, TEK, TNKS, TNKS2 | 5.74852 |
[BP] GO:0007166 | cell surface receptor signaling pathway | ADORA1, ADORA3, APP, AXL, BCL2, CA1, CSNK2A1, EGFR, F3, FLT3, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, IGF1R, INSR, KDR, MET, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2 | 5.74852 |
[BP] GO:0046777 | protein autophosphorylation | AURKB, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, PIM1, SRC, TEK | 5.73456 |
[BP] GO:0006730 | one-carbon metabolic process | CA1, CA12, CA2, CA4, CA7, CA9 | 5.70203 |
[BP] GO:0010562 | positive regulation of phosphorus metabolic process | ADORA1, APP, BCL2, CDC25B, CHRNA3, CHRNA7, EGFR, ESRRB, FABP3, FLT3, GRM1, GRM5, HMGCR, INSR, KDR, PTPN1, SMAD3, SRC, TEK, XDH | 5.66699 |
[BP] GO:0045937 | positive regulation of phosphate metabolic process | ADORA1, APP, BCL2, CDC25B, CHRNA3, CHRNA7, EGFR, ESRRB, FABP3, FLT3, GRM1, GRM5, HMGCR, INSR, KDR, PTPN1, SMAD3, SRC, TEK, XDH | 5.66699 |
[BP] GO:0009628 | response to abiotic stimulus | ADORA1, AKR1B1, APP, AURKB, BCL2, CA2, CHRNA7, CYP1A1, EDNRA, EGFR, GRM1, HMGCR, HSD11B2, HSPA1A, PPARA, SMAD3, SRC, TEK, TYR | 5.55519 |
[BP] GO:0055114 | oxidation-reduction process | AKR1B1, AKR1B10, ALDH2, ALOX5, AOX1, CBR1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, GAA, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2, TYR, XDH | 5.5316 |
[BP] GO:0051338 | regulation of transferase activity | ADORA1, APP, AURKB, CDC25B, CHRNA3, CHRNA7, DUSP3, EGFR, FABP4, FLT3, GRM1, GRM5, HMGCR, IGF1R, INSR, PTPN1, SRC, TEK, TNKS | 5.48551 |
[BP] GO:0010817 | regulation of hormone levels | ACHE, ADORA1, AKR1B1, CHRNA3, CYP19A1, CYP1A1, CYP1B1, EGFR, ESR1, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2 | 5.47388 |
[BP] GO:0043067 | regulation of programmed cell death | ADORA1, AKR1B1, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, EGFR, ESR1, F3, FLT3, GRIK5, HMGCR, HSPA1A, IGF1R, KDR, MET, PIM1, PTPN1, SMAD3, SRC, TEK, XDH | 5.46214 |
[BP] GO:0051173 | positive regulation of nitrogen compound metabolic process | ADORA1, APP, AURKB, BCL2, CDC25B, CHRNA3, CHRNA7, CSNK2A1, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, GRM1, GRM5, HMGCR, HSPA1A, IGF1R, INSR, KDR, MET, PPARA, PTPN1, RORC, SMAD3, SRC, TEK, TNKS, TNKS2, XDH | 5.30831 |
[BP] GO:0043085 | positive regulation of catalytic activity | ADORA1, APP, AURKB, BCL2, CDC25B, CHRNA3, CHRNA7, EDNRA, EGFR, ESR1, F3, FLT3, GRM1, GRM5, HSPA1A, INSR, PTPN1, SMAD3, SRC, TEK, TNKS, XDH | 5.2907 |
[BP] GO:0006468 | protein phosphorylation | APP, AURKB, AXL, BCL2, CDC25B, CDK6, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK, TNKS | 5.27546 |
[BP] GO:0060078 | None | ADORA1, CHRNA3, CHRNA7, GRIA2, GRIA4, GRIK5, GRM5 | 5.19377 |
[BP] GO:0060548 | negative regulation of cell death | ADORA1, AKR1B1, AURKB, AXL, BCL2, CSNK2A1, EGFR, HMGCR, HSPA1A, IGF1R, KDR, MET, PIM1, PPARA, PTPN1, SMAD3, SRC, TEK | 5.19377 |
[BP] GO:0048584 | positive regulation of response to stimulus | ADORA1, AKR1B1, APP, AXL, BCL2, CHRNA7, CSNK2A1, CYP1B1, EGFR, ESRRA, F3, FABP4, FLT3, GPR35, GRM1, HMGCR, HSPA1A, INSR, KDR, MET, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, XDH | 5.14631 |
[BP] GO:0043549 | regulation of kinase activity | ADORA1, APP, CDC25B, CHRNA3, CHRNA7, DUSP3, EGFR, FABP4, FLT3, GRM1, GRM5, HMGCR, IGF1R, INSR, PTPN1, SRC, TEK | 5.14386 |
[BP] GO:0008152 | metabolic process | ACHE, ADORA1, AKR1B1, AKR1B10, ALDH2, ALOX5, ALPL, AOX1, APP, AURKB, AXL, BCL2, CA1, CA12, CA2, CA4, CA7, CA9, CBR1, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, FUT7, GAA, GBA2, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSPA1A, IGF1R, INSR, KDR, MET, MGAM, NUAK1, PIM1, PPARA, PTPN1, RORC, SMAD3, SRC, TEK, TNKS, TNKS2, TYR, XDH | 5.13083 |
[BP] GO:0007196 | None | GRM1, GRM3, GRM5, GRM8 | 5.11536 |
[BP] GO:0044093 | positive regulation of molecular function | ADORA1, APP, AURKB, BCL2, CDC25B, CHRNA3, CHRNA7, EDNRA, EGFR, ESR1, ESR2, F3, FLT3, GRM1, GRM5, HSPA1A, INSR, MET, PTPN1, SMAD3, SRC, TEK, TNKS, XDH | 5.11184 |
[BP] GO:0071310 | cellular response to organic substance | AKR1B1, ALPL, APP, AXL, BCL2, CDK6, CYP1A1, CYP1B1, EGFR, ESR1, FABP4, FLT3, GRIK5, GRM5, IGF1R, INSR, KDR, RORC, SMAD3, SRC | 5.06823 |
[BP] GO:0043069 | negative regulation of programmed cell death | ADORA1, AKR1B1, AURKB, AXL, BCL2, CSNK2A1, EGFR, HMGCR, HSPA1A, IGF1R, KDR, MET, PIM1, PTPN1, SMAD3, SRC, TEK | 5.0339 |
[BP] GO:0070887 | cellular response to chemical stimulus | AKR1B1, ALPL, APP, AXL, BCL2, CDK6, CYP1A1, CYP1A2, CYP1B1, EGFR, ESR1, FABP4, FLT3, GRIK5, GRM5, HSPA1A, IGF1R, INSR, KDR, RORC, SMAD3, SRC | 5.0339 |
[BP] GO:0031325 | positive regulation of cellular metabolic process | ADORA1, APP, AURKB, BCL2, CDC25B, CHRNA3, CHRNA7, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FLT3, GRM1, GRM5, HMGCR, HSPA1A, IGF1R, INSR, KDR, MET, PPARA, PTPN1, RORC, SMAD3, SRC, TEK, TNKS, TNKS2, XDH | 5.0229 |
[BP] GO:0042327 | positive regulation of phosphorylation | ADORA1, APP, BCL2, CDC25B, CHRNA3, CHRNA7, EGFR, ESRRB, FLT3, GRM1, GRM5, HMGCR, INSR, KDR, PTPN1, SRC, TEK, XDH | 5.01431 |
[BP] GO:0050896 | response to stimulus | ACHE, ADORA1, ADORA3, AKR1B1, ALPL, APP, AURKB, AXL, BCL2, CA2, CA9, CDK6, CHRNA3, CHRNA7, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, EDNRA, EGFR, ESR1, ESRRA, F3, FABP3, FABP4, FLT3, GRIK5, GRM1, GRM5, HMGCR, HSD11B2, HSD17B2, HSPA1A, IGF1R, INSR, KDR, NUAK1, PPARA, PTPN1, RORC, SMAD3, SRC, TEK, TYR | 5.01431 |
[BP] GO:0010604 | positive regulation of macromolecule metabolic process | ADORA1, APP, AURKB, BCL2, CDC25B, CHRNA3, CHRNA7, CSNK2A1, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, GRM1, GRM5, HMGCR, HSPA1A, IGF1R, INSR, KDR, MET, PPARA, PTPN1, RORC, SMAD3, SRC, TEK, TNKS, TNKS2, XDH | 4.98842 |
[BP] GO:0042325 | regulation of phosphorylation | ADORA1, APP, BCL2, CDC25B, CHRNA3, CHRNA7, DUSP3, EGFR, ESRRB, FABP4, FLT3, GRM1, GRM5, HMGCR, IGF1R, INSR, KDR, PPARA, PTPN1, SRC, TEK, XDH | 4.98023 |
[BP] GO:0042981 | regulation of apoptotic process | ADORA1, AKR1B1, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, EGFR, ESR1, F3, FLT3, GRIK5, HMGCR, HSPA1A, IGF1R, KDR, PIM1, PTPN1, SMAD3, SRC, TEK, XDH | 4.97979 |
[BP] GO:0018108 | peptidyl-tyrosine phosphorylation | AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, SRC, TEK | 4.95901 |
[BP] GO:0042391 | None | ADORA1, APP, BCL2, CHRNA3, CHRNA7, GPR35, GRIA2, GRIA4, GRIK5, GRM5, KDR, SRC | 4.94916 |
[BP] GO:0018212 | peptidyl-tyrosine modification | AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, SRC, TEK | 4.91268 |
[BP] GO:0045859 | regulation of protein kinase activity | ADORA1, APP, CDC25B, CHRNA3, CHRNA7, DUSP3, EGFR, FABP4, FLT3, GRM1, GRM5, HMGCR, IGF1R, INSR, PTPN1, SRC | 4.89142 |
[BP] GO:0006796 | phosphate-containing compound metabolic process | ACHE, ALPL, APP, AURKB, AXL, BCL2, CDC25B, CDK6, CSNK2A1, DUSP3, EGFR, FLT3, HMGCR, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, PTPN1, SRC, TEK, TNKS, XDH | 4.89068 |
[BP] GO:0009893 | positive regulation of metabolic process | ADORA1, APP, AURKB, BCL2, CDC25B, CHRNA3, CHRNA7, CSNK2A1, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FLT3, GRM1, GRM5, HMGCR, HSPA1A, IGF1R, INSR, KDR, MET, PPARA, PTPN1, RORC, SMAD3, SRC, TEK, TNKS, TNKS2, XDH | 4.86013 |
[BP] GO:0001666 | response to hypoxia | ADORA1, BCL2, CHRNA7, CYP1A1, EDNRA, HSD11B2, PPARA, SMAD3, SRC, TEK | 4.8341 |
[BP] GO:0048523 | negative regulation of cellular process | ACHE, ADORA1, ADORA3, AKR1B1, APP, AURKB, AXL, BCL2, CDK6, CHRNA7, CSNK2A1, CYP19A1, CYP1B1, DUSP3, EDNRA, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, GPR35, GRM3, GRM8, HMGCR, HSPA1A, IGF1R, KDR, MET, PIM1, PPARA, PTPN1, RORC, SMAD3, SRC, TEK, TNKS, TNKS2, XDH | 4.81509 |
[BP] GO:0032879 | regulation of localization | ACHE, ADORA1, ADORA3, APP, AXL, BCL2, CA2, CA7, CDK6, CHRNA3, CSNK2A1, CYP19A1, CYP1B1, EGFR, F3, GPR35, GRIK5, GRM5, HMGCR, HSPA1A, IGF1R, INSR, KDR, MET, PPARA, PTPN1, SMAD3, SRC, TEK | 4.7499 |
[BP] GO:0043405 | regulation of MAP kinase activity | ADORA1, CHRNA7, DUSP3, EGFR, FLT3, GRM1, HMGCR, IGF1R, INSR, PTPN1, SRC | 4.7417 |
[BP] GO:0043410 | positive regulation of MAPK cascade | ADORA1, APP, CHRNA7, EGFR, FLT3, GRM1, HMGCR, INSR, KDR, PTPN1, SRC, TEK, XDH | 4.7417 |
[BP] GO:0036293 | response to decreased oxygen levels | ADORA1, BCL2, CHRNA7, CYP1A1, EDNRA, HSD11B2, PPARA, SMAD3, SRC, TEK | 4.73113 |
[BP] GO:0048583 | regulation of response to stimulus | ADORA1, AKR1B1, APP, AURKB, AXL, BCL2, CDK6, CHRNA3, CHRNA7, CSNK2A1, CYP19A1, CYP1B1, DUSP3, EGFR, ESR1, ESR2, ESRRA, F3, FABP4, FLT3, GPR35, GRM1, HMGCR, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PPARA, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, XDH | 4.725 |
[BP] GO:0044237 | cellular metabolic process | ACHE, AKR1B1, AKR1B10, ALDH2, ALOX5, ALPL, AOX1, APP, AURKB, AXL, BCL2, CA1, CA12, CA2, CA4, CA7, CA9, CBR1, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, FUT7, GAA, GBA2, HMGCR, HSD17B1, HSD17B2, HSPA1A, IGF1R, INSR, KDR, MET, MGAM, NUAK1, PIM1, PPARA, PTPN1, RORC, SMAD3, SRC, TEK, TNKS, TNKS2, TYR, XDH | 4.7103 |
[BP] GO:2000145 | regulation of cell motility | ADORA1, ADORA3, APP, BCL2, CDK6, CYP19A1, CYP1B1, EGFR, F3, IGF1R, INSR, KDR, MET, SMAD3, SRC, TEK | 4.69049 |
[BP] GO:0043408 | regulation of MAPK cascade | ADORA1, APP, CHRNA7, DUSP3, EGFR, FLT3, GRM1, HMGCR, IGF1R, INSR, KDR, PTPN1, SRC, TEK, XDH | 4.67885 |
[BP] GO:1901652 | response to peptide | AKR1B1, APP, CHRNA7, FABP3, GRM5, HSD11B2, IGF1R, INSR, PPARA, SRC, TEK | 4.66247 |
[BP] GO:0051966 | regulation of synaptic transmission, glutamatergic | ADORA1, EGFR, GRM1, GRM3, GRM5, GRM8 | 4.66247 |
[BP] GO:0001934 | positive regulation of protein phosphorylation | ADORA1, APP, BCL2, CDC25B, CHRNA3, CHRNA7, EGFR, FLT3, GRM1, GRM5, HMGCR, INSR, KDR, PTPN1, SRC, TEK, XDH | 4.64664 |
[BP] GO:0051239 | regulation of multicellular organismal process | ADORA1, ADORA3, APP, AXL, BCL2, CA2, CDK6, CHRNA3, CHRNA7, CYP1B1, EGFR, ESR1, ESRRA, ESRRB, F3, GAA, GPR35, GRM1, HMGCR, HSPA1A, INSR, KDR, MET, PIM1, SLC1A1, SMAD3, SRC, TEK, TNKS2, XDH | 4.59367 |
[BP] GO:0042446 | hormone biosynthetic process | AKR1B1, CYP19A1, HSD11B1, HSD11B2, HSD17B1, HSD17B2 | 4.58554 |
[BP] GO:0006793 | phosphorus metabolic process | ACHE, ALPL, APP, AURKB, AXL, BCL2, CDC25B, CDK6, CSNK2A1, DUSP3, EGFR, FLT3, HMGCR, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, PTPN1, SRC, TEK, TNKS, XDH | 4.58145 |
[BP] GO:0042493 | response to drug | AKR1B1, AXL, BCL2, CA9, CDK6, CHRNA3, CHRNA7, CYP1A1, CYP1B1, EGFR, FABP3, HMGCR, HSD11B2, KDR, SRC | 4.57075 |
[BP] GO:0051247 | positive regulation of protein metabolic process | ADORA1, APP, BCL2, CDC25B, CHRNA3, CHRNA7, CSNK2A1, EGFR, ESR1, F3, FLT3, GRM1, GRM5, HMGCR, HSPA1A, INSR, KDR, PTPN1, SMAD3, SRC, TEK, XDH | 4.5393 |
[BP] GO:0043066 | negative regulation of apoptotic process | ADORA1, AKR1B1, AURKB, AXL, BCL2, CSNK2A1, EGFR, HMGCR, HSPA1A, IGF1R, KDR, PIM1, PTPN1, SMAD3, SRC, TEK | 4.51025 |
[BP] GO:0009966 | regulation of signal transduction | ADORA1, AKR1B1, APP, AURKB, AXL, BCL2, CHRNA7, CSNK2A1, CYP1B1, DUSP3, EGFR, ESR1, ESR2, F3, FLT3, GPR35, GRM1, HMGCR, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, XDH | 4.45085 |
[BP] GO:0070482 | response to oxygen levels | ADORA1, BCL2, CHRNA7, CYP1A1, EDNRA, HSD11B2, PPARA, SMAD3, SRC, TEK | 4.44723 |
[BP] GO:0007216 | None | GRM1, GRM3, GRM5, GRM8 | 4.43005 |
[BP] GO:0034754 | cellular hormone metabolic process | AKR1B1, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD17B1, HSD17B2 | 4.41936 |
[BP] GO:0032847 | regulation of cellular pH reduction | BCL2, CA2, CA7 | 4.40438 |
[BP] GO:0010035 | response to inorganic substance | AKR1B1, APP, AXL, BCL2, CA2, CYP1A1, CYP1A2, CYP1B1, EGFR, FABP4, KDR, SRC | 4.40356 |
[BP] GO:0001932 | regulation of protein phosphorylation | ADORA1, APP, BCL2, CDC25B, CHRNA3, CHRNA7, DUSP3, EGFR, FABP4, FLT3, GRM1, GRM5, HMGCR, IGF1R, INSR, KDR, PTPN1, SRC, TEK, XDH | 4.38998 |
[BP] GO:0008284 | positive regulation of cell proliferation | AKR1B1, BCL2, CDC25B, CDK6, CHRNA7, CSNK2A1, EGFR, ESR1, F3, FLT3, HMGCR, IGF1R, INSR, KDR, PIM1, TEK | 4.34245 |
[BP] GO:0030334 | regulation of cell migration | ADORA1, ADORA3, APP, BCL2, CYP19A1, CYP1B1, EGFR, F3, IGF1R, INSR, KDR, MET, SMAD3, SRC, TEK | 4.34193 |
[BP] GO:0032270 | positive regulation of cellular protein metabolic process | ADORA1, APP, BCL2, CDC25B, CHRNA3, CHRNA7, EGFR, ESR1, F3, FLT3, GRM1, GRM5, HMGCR, HSPA1A, INSR, KDR, PTPN1, SMAD3, SRC, TEK, XDH | 4.33219 |
[BP] GO:0060079 | None | ADORA1, CHRNA3, CHRNA7, GRIA2, GRIA4, GRIK5 | 4.32177 |
[BP] GO:0050801 | ion homeostasis | APP, BCL2, CA12, CA2, CA7, CHRNA7, EDNRA, EGFR, ESR1, FABP3, GPR35, GRM1, GRM5, SMAD3 | 4.32177 |
[BP] GO:0040012 | regulation of locomotion | ADORA1, ADORA3, APP, BCL2, CDK6, CYP19A1, CYP1B1, EGFR, F3, IGF1R, INSR, KDR, MET, SMAD3, SRC, TEK | 4.31912 |
[BP] GO:0032844 | regulation of homeostatic process | ADORA1, AURKB, BCL2, CA2, CA7, CDK6, EGFR, HMGCR, KDR, SRC, TNKS, TNKS2 | 4.30581 |
[BP] GO:0051270 | regulation of cellular component movement | ADORA1, ADORA3, APP, BCL2, CDK6, CYP19A1, CYP1B1, EGFR, F3, IGF1R, INSR, KDR, MET, SMAD3, SRC, TEK | 4.30581 |
[BP] GO:0051716 | cellular response to stimulus | AKR1B1, ALPL, APP, AURKB, AXL, BCL2, CA2, CA9, CDK6, CYP1A1, CYP1A2, CYP1B1, EGFR, ESR1, FABP4, FLT3, GRIK5, GRM1, GRM5, HSPA1A, IGF1R, INSR, KDR, NUAK1, PTPN1, RORC, SMAD3, SRC | 4.29163 |
[BP] GO:0016310 | phosphorylation | APP, AURKB, AXL, BCL2, CDC25B, CDK6, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK, TNKS | 4.22942 |
[BP] GO:0051347 | positive regulation of transferase activity | ADORA1, AURKB, CDC25B, CHRNA3, CHRNA7, EGFR, FLT3, GRM1, GRM5, INSR, PTPN1, SRC, TEK, TNKS | 4.21986 |
[BP] GO:0030522 | intracellular receptor signaling pathway | ESR1, ESR2, ESRRA, ESRRB, PIM1, PPARA, RORC, SRC | 4.18839 |
[BP] GO:0044092 | negative regulation of molecular function | ADORA3, APP, AURKB, CSNK2A1, CYP1B1, DUSP3, ESR1, FABP4, GPR35, GRM3, HMGCR, IGF1R, MET, PIM1, PPARA, PTPN1, SRC, TNKS | 4.16179 |
[BP] GO:1901698 | response to nitrogen compound | AKR1B1, APP, CHRNA3, CHRNA7, EGFR, FABP3, FLT3, GRM5, HSD11B2, IGF1R, INSR, PPARA, SRC, TEK, TYR | 4.04657 |
[BP] GO:0080134 | regulation of response to stress | ADORA1, APP, CDK6, CYP19A1, DUSP3, EGFR, ESR1, F3, FABP4, HMGCR, HSPA1A, IGF1R, MET, NUAK1, PPARA, PTPN1, SMAD3, SRC, TEK, XDH | 4.03895 |
[BP] GO:1901615 | organic hydroxy compound metabolic process | AKR1B1, AKR1B10, ALDH2, APP, BCL2, CYP19A1, CYP1A1, CYP1B1, GBA2, HMGCR, TYR | 4.03895 |
[BP] GO:0006694 | steroid biosynthetic process | AKR1B1, CYP19A1, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2 | 4.03514 |
[BP] GO:0031399 | regulation of protein modification process | ADORA1, APP, BCL2, CDC25B, CHRNA3, CHRNA7, DUSP3, EGFR, FABP4, FLT3, GRM1, GRM5, HMGCR, HSPA1A, IGF1R, INSR, KDR, NUAK1, PTPN1, SRC, TEK, XDH | 3.97178 |
[BP] GO:0043401 | steroid hormone mediated signaling pathway | ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC, SRC | 3.95207 |
[BP] GO:0044255 | cellular lipid metabolic process | ACHE, AKR1B10, ALOX5, CBR1, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, EGFR, FABP3, FABP4, FUT7, GBA2, HMGCR, MET, PPARA | 3.91208 |
[BP] GO:0048519 | negative regulation of biological process | ACHE, ADORA1, ADORA3, AKR1B1, APP, AURKB, AXL, BCL2, CDK6, CHRNA7, CSNK2A1, CYP19A1, CYP1B1, DUSP3, EDNRA, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, GPR35, GRM3, GRM8, HMGCR, HSPA1A, IGF1R, KDR, MET, PIM1, PPARA, PTPN1, RORC, SMAD3, SRC, TEK, TNKS, TNKS2, XDH | 3.81605 |
[BP] GO:0038083 | peptidyl-tyrosine autophosphorylation | EGFR, IGF1R, INSR, KDR, SRC | 3.81441 |
[BP] GO:0030335 | positive regulation of cell migration | APP, BCL2, EGFR, F3, IGF1R, INSR, KDR, MET, SMAD3, SRC, TEK | 3.78586 |
[BP] GO:0098771 | inorganic ion homeostasis | APP, BCL2, CA12, CA2, CA7, CHRNA7, EDNRA, EGFR, ESR1, GPR35, GRM1, GRM5, SMAD3 | 3.7824 |
[BP] GO:0044238 | primary metabolic process | ACHE, ADORA1, AKR1B1, AKR1B10, ALDH2, ALOX5, ALPL, AOX1, APP, AURKB, AXL, BCL2, CBR1, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, FUT7, GAA, GBA2, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSPA1A, IGF1R, INSR, KDR, MET, MGAM, NUAK1, PIM1, PPARA, PTPN1, RORC, SMAD3, SRC, TEK, TNKS, TNKS2, TYR, XDH | 3.77732 |
[BP] GO:0070372 | regulation of ERK1 and ERK2 cascade | APP, CHRNA7, DUSP3, EGFR, HMGCR, KDR, PTPN1, SRC, TEK | 3.77418 |
[BP] GO:0010243 | response to organonitrogen compound | AKR1B1, APP, CHRNA7, EGFR, FABP3, FLT3, GRM5, HSD11B2, IGF1R, INSR, PPARA, SRC, TEK, TYR | 3.73579 |
[BP] GO:0033674 | positive regulation of kinase activity | ADORA1, CDC25B, CHRNA3, CHRNA7, EGFR, FLT3, GRM1, GRM5, INSR, PTPN1, SRC, TEK | 3.72622 |
[BP] GO:0008283 | cell proliferation | ACHE, AURKB, BCL2, CYP1A1, EDNRA, EGFR, ESR1, FLT3, MET, PIM1, SRC, TEK, TYR | 3.71175 |
[BP] GO:0002009 | morphogenesis of an epithelium | BCL2, CA2, CA9, EDNRA, EGFR, ESR1, MET, SMAD3, SRC | 3.68655 |
[BP] GO:0007346 | regulation of mitotic cell cycle | APP, AURKB, BCL2, CDC25B, CDK6, CYP1A1, DUSP3, EGFR, HSPA1A, INSR, PIM1, SMAD3, TNKS | 3.68542 |
[BP] GO:2000147 | positive regulation of cell motility | APP, BCL2, EGFR, F3, IGF1R, INSR, KDR, MET, SMAD3, SRC, TEK | 3.6699 |
[BP] GO:0051896 | regulation of protein kinase B signaling | AXL, EGFR, F3, INSR, MET, SRC, TEK, XDH | 3.652 |
[BP] GO:0051272 | positive regulation of cellular component movement | APP, BCL2, EGFR, F3, IGF1R, INSR, KDR, MET, SMAD3, SRC, TEK | 3.56712 |
[BP] GO:0008210 | estrogen metabolic process | CYP19A1, CYP1B1, HSD17B1, HSD17B2 | 3.56712 |
[BP] GO:0051897 | positive regulation of protein kinase B signaling | AXL, EGFR, F3, INSR, MET, SRC, TEK | 3.56126 |
[BP] GO:0019222 | regulation of metabolic process | ACHE, ADORA1, ADORA3, APP, AURKB, BCL2, CA9, CDC25B, CDK6, CHRNA3, CHRNA7, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DUSP3, EDNRA, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, GRM1, GRM3, GRM5, GRM8, HMGCR, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, PPARA, PTPN1, RORC, SMAD3, SRC, TEK, TNKS, TNKS2, XDH | 3.50717 |
[BP] GO:0009892 | negative regulation of metabolic process | ADORA1, APP, AURKB, BCL2, CHRNA7, CSNK2A1, DUSP3, EDNRA, EGFR, ESR1, ESR2, ESRRA, FABP4, GRM3, GRM8, HMGCR, HSPA1A, IGF1R, KDR, MET, PPARA, PTPN1, RORC, SMAD3, SRC, TNKS, TNKS2, XDH | 3.46196 |
[BP] GO:0051701 | interaction with host | AXL, EGFR, HSPA1A, INSR, MET, SMAD3, SRC | 3.46134 |
[BP] GO:0035235 | None | APP, GRIA2, GRIA4, GRIK5 | 3.44057 |
[BP] GO:0040017 | positive regulation of locomotion | APP, BCL2, EGFR, F3, IGF1R, INSR, KDR, MET, SMAD3, SRC, TEK | 3.44057 |
[BP] GO:0001952 | regulation of cell-matrix adhesion | BCL2, CDK6, KDR, SMAD3, SRC, TEK | 3.43233 |
[BP] GO:0031401 | positive regulation of protein modification process | ADORA1, APP, BCL2, CDC25B, CHRNA3, CHRNA7, EGFR, FLT3, GRM1, GRM5, HMGCR, INSR, KDR, PTPN1, SRC, TEK, XDH | 3.38598 |
[BP] GO:0009636 | response to toxic substance | AKR1B1, ALPL, AXL, BCL2, CHRNA7, CYP1A1, CYP1B1, HMGCR, KDR, SRC | 3.36847 |
[BP] GO:0050793 | regulation of developmental process | APP, AXL, BCL2, CA2, CDK6, CHRNA3, CHRNA7, CYP1B1, EGFR, ESR1, ESRRA, ESRRB, F3, HMGCR, INSR, KDR, NUAK1, PIM1, PPARA, RORC, SMAD3, SRC, TEK, TNKS2, XDH | 3.36847 |
[BP] GO:0071900 | regulation of protein serine/threonine kinase activity | ADORA1, CHRNA7, DUSP3, EGFR, FLT3, GRM1, HMGCR, IGF1R, INSR, PTPN1, SRC | 3.33524 |
[BP] GO:0009755 | hormone-mediated signaling pathway | ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC, SRC | 3.33272 |
[BP] GO:0045860 | positive regulation of protein kinase activity | ADORA1, CDC25B, CHRNA3, CHRNA7, EGFR, FLT3, GRM1, GRM5, INSR, PTPN1, SRC | 3.2589 |
[BP] GO:0072507 | divalent inorganic cation homeostasis | APP, BCL2, CHRNA7, EDNRA, EGFR, ESR1, GPR35, GRM1, GRM5, SMAD3 | 3.23991 |
[BP] GO:0015711 | organic anion transport | CA1, CA12, CA14, CA2, CA4, CA7, CA9, FABP3, PPARA, SLC1A1 | 3.23991 |
[BP] GO:0003008 | None | ADORA1, AKR1B1, APP, BCL2, CHRNA7, CYP1B1, EDNRA, EGFR, GAA, GRM1, GRM5, GRM8, HMGCR, HSD11B2, INSR, SRC, TEK, TYR | 3.23991 |
[BP] GO:0051171 | regulation of nitrogen compound metabolic process | ADORA1, ADORA3, APP, AURKB, BCL2, CA9, CDC25B, CHRNA3, CHRNA7, CSNK2A1, CYP1B1, DUSP3, EDNRA, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, GRM1, GRM3, GRM5, GRM8, HMGCR, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, PPARA, PTPN1, RORC, SMAD3, SRC, TEK, TNKS, TNKS2, XDH | 3.23991 |
[BP] GO:0080090 | regulation of primary metabolic process | ADORA1, ADORA3, APP, AURKB, BCL2, CA9, CDC25B, CHRNA3, CHRNA7, CSNK2A1, CYP1A1, CYP1B1, DUSP3, EDNRA, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, GRM1, GRM3, GRM5, GRM8, HMGCR, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, PPARA, PTPN1, RORC, SMAD3, SRC, TEK, TNKS, TNKS2, XDH | 3.23991 |
[BP] GO:1904645 | response to amyloid-beta | APP, CHRNA7, GRM5, IGF1R | 3.23523 |
[BP] GO:0055080 | cation homeostasis | APP, BCL2, CA2, CA7, CHRNA7, EDNRA, EGFR, ESR1, GPR35, GRM1, GRM5, SMAD3 | 3.21464 |
[BP] GO:0031323 | regulation of cellular metabolic process | ACHE, ADORA1, ADORA3, APP, AURKB, BCL2, CA9, CDC25B, CHRNA3, CHRNA7, CSNK2A1, CYP1B1, DUSP3, EDNRA, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, GRM1, GRM3, GRM5, GRM8, HMGCR, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, PPARA, PTPN1, RORC, SMAD3, SRC, TEK, TNKS, TNKS2, XDH | 3.19224 |
[BP] GO:0032268 | regulation of cellular protein metabolic process | ADORA1, APP, BCL2, CDC25B, CHRNA3, CHRNA7, CSNK2A1, DUSP3, EGFR, ESR1, F3, FABP4, FLT3, GRM1, GRM5, HMGCR, HSPA1A, IGF1R, INSR, KDR, NUAK1, PTPN1, SMAD3, SRC, TEK, XDH | 3.18254 |
[BP] GO:0017144 | drug metabolic process | ACHE, AKR1B1, AKR1B10, ALDH2, AOX1, CBR1, CYP1A1, CYP1A2, CYP1B1, EGFR, HSPA1A | 3.17537 |
[BP] GO:0009611 | response to wounding | ACHE, ADORA3, BCL2, CYP1A1, EGFR, PPARA, SMAD3 | 3.17318 |
[BP] GO:2001225 | regulation of chloride transport | CA2, CA7, GRM5 | 3.16252 |
[BP] GO:0097267 | omega-hydroxylase P450 pathway | CYP1A1, CYP1A2, CYP1B1 | 3.16252 |
[BP] GO:1901701 | cellular response to oxygen-containing compound | AKR1B1, APP, AXL, CDK6, CYP1B1, EGFR, ESR1, GRIK5, GRM5, IGF1R, INSR, RORC, SRC | 3.15497 |
[BP] GO:0001505 | regulation of neurotransmitter levels | ACHE, CHRNA3, CYP1B1, EGFR, GRIK5, INSR, SLC1A1, SMAD3 | 3.14812 |
[BP] GO:0071704 | organic substance metabolic process | ACHE, ADORA1, AKR1B1, AKR1B10, ALDH2, ALOX5, ALPL, AOX1, APP, AURKB, AXL, BCL2, CBR1, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, FUT7, GAA, GBA2, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSPA1A, IGF1R, INSR, KDR, MET, MGAM, NUAK1, PIM1, PPARA, PTPN1, RORC, SMAD3, SRC, TEK, TNKS, TNKS2, TYR, XDH | 3.10413 |
[BP] GO:0007610 | None | APP, BCL2, CHRNA3, CHRNA7, EGFR, GAA, GRM1, GRM5, HMGCR, INSR, PPARA | 3.10096 |
[BP] GO:0050806 | positive regulation of synaptic transmission | ADORA1, APP, CA2, CA7, CHRNA7, EGFR | 3.10096 |
[BP] GO:0010907 | None | ESRRB, INSR, PPARA, SRC | 3.0969 |
[BP] GO:0106027 | None | APP, CHRNA7, IGF1R, INSR | 3.0969 |
[BP] GO:0055082 | cellular chemical homeostasis | APP, BCL2, CA2, CA7, CHRNA7, EDNRA, ESR1, GPR35, GRIK5, GRM1, GRM5, SMAD3 | 3.07725 |
[BP] GO:0043406 | positive regulation of MAP kinase activity | ADORA1, CHRNA7, EGFR, FLT3, GRM1, INSR, PTPN1, SRC | 3.05563 |
[BP] GO:0071407 | cellular response to organic cyclic compound | ALPL, APP, CYP1A1, CYP1B1, EGFR, ESR1, FLT3, RORC, SRC | 3.0453 |
[BP] GO:0006720 | isoprenoid metabolic process | AKR1B10, CYP1A1, CYP1A2, CYP1B1, EGFR, HMGCR | 3.0332 |
[BP] GO:0048729 | tissue morphogenesis | BCL2, CA2, CA9, EDNRA, EGFR, ESR1, MET, SMAD3, SRC | 3.00972 |
[BP] GO:0016042 | lipid catabolic process | ADORA1, AKR1B10, CYP19A1, CYP1A2, CYP1B1, FABP3, FABP4, GBA2 | 2.99221 |
[BP] GO:0019725 | cellular homeostasis | APP, BCL2, CA2, CA7, CHRNA7, EDNRA, ESR1, GAA, GPR35, GRIK5, GRM1, GRM5, SMAD3 | 2.98481 |
[BP] GO:0009987 | cellular process | ACHE, ADORA1, ADORA3, AKR1B1, AKR1B10, ALDH2, ALOX5, ALPL, AOX1, APP, AURKB, AXL, BCL2, CA1, CA12, CA2, CA4, CA7, CA9, CBR1, CDC25B, CDK6, CHRNA3, CHRNA7, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DUSP3, EDNRA, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, FUT7, GAA, GBA2, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HMGCR, HSD17B1, HSD17B2, HSPA1A, IGF1R, INSR, KDR, MET, MGAM, NUAK1, PIM1, PPARA, PTPN1, RORC, SLC1A1, SMAD3, SRC, TEK, TNKS, TNKS2, TYR, XDH | 2.95039 |
[BP] GO:0007193 | None | ADORA1, GRM1, GRM3, GRM5, GRM8 | 2.94828 |
[BP] GO:0070374 | positive regulation of ERK1 and ERK2 cascade | APP, CHRNA7, EGFR, HMGCR, KDR, SRC, TEK | 2.94726 |
[BP] GO:0019216 | regulation of lipid metabolic process | ADORA1, CYP1A1, FABP3, FLT3, HMGCR, PPARA, RORC, SRC, TEK | 2.94726 |
[BP] GO:0030003 | cellular cation homeostasis | APP, BCL2, CA2, CA7, CHRNA7, EDNRA, ESR1, GPR35, GRM1, GRM5, SMAD3 | 2.93795 |
[BP] GO:0048585 | negative regulation of response to stimulus | ADORA1, BCL2, CDK6, CYP19A1, DUSP3, EGFR, ESR1, ESR2, HMGCR, HSPA1A, IGF1R, MET, PPARA, PTPN1, SMAD3, SRC, TEK, XDH | 2.90012 |
[BP] GO:0048869 | cellular developmental process | ACHE, ALPL, APP, AXL, BCL2, CBR1, CDC25B, CDK6, CHRNA7, CYP1A1, EDNRA, EGFR, ESR1, ESRRB, FABP4, FLT3, FUT7, GBA2, HMGCR, KDR, MET, RORC, SMAD3, SRC, TEK | 2.88278 |
[BP] GO:0009115 | None | AOX1, XDH | 2.87243 |
[BP] GO:0048511 | rhythmic process | AXL, BCL2, CSNK2A1, EGFR, ESR1, PPARA, RORC, SRC | 2.86224 |
[BP] GO:0006873 | cellular ion homeostasis | APP, BCL2, CA2, CA7, CHRNA7, EDNRA, ESR1, GPR35, GRM1, GRM5, SMAD3 | 2.85177 |
[BP] GO:0006703 | estrogen biosynthetic process | CYP19A1, HSD17B1, HSD17B2 | 2.85025 |
[BP] GO:0031324 | negative regulation of cellular metabolic process | APP, AURKB, BCL2, CHRNA7, CSNK2A1, DUSP3, EDNRA, ESR1, ESR2, ESRRA, FABP4, GRM3, GRM8, HMGCR, HSPA1A, IGF1R, MET, PPARA, PTPN1, RORC, SMAD3, SRC, TNKS, TNKS2, XDH | 2.84341 |
[BP] GO:0006874 | cellular calcium ion homeostasis | APP, BCL2, CHRNA7, EDNRA, ESR1, GPR35, GRM1, GRM5, SMAD3 | 2.80521 |
[BP] GO:0051172 | None | APP, AURKB, CHRNA7, CSNK2A1, DUSP3, EDNRA, EGFR, ESR1, ESR2, ESRRA, FABP4, GRM3, GRM8, HMGCR, HSPA1A, IGF1R, PPARA, PTPN1, RORC, SMAD3, SRC, TNKS, TNKS2, XDH | 2.80321 |
[BP] GO:0009056 | catabolic process | ACHE, ADORA1, AKR1B10, ALDH2, AOX1, AURKB, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, FABP3, FABP4, FUT7, GAA, GBA2, HSPA1A, MGAM, SRC, XDH | 2.78086 |
[BP] GO:0051054 | positive regulation of DNA metabolic process | AURKB, EGFR, IGF1R, INSR, SRC, TNKS, TNKS2 | 2.76371 |
[BP] GO:0060065 | uterus development | CYP19A1, ESR1, SRC | 2.76371 |
[BP] GO:0051240 | positive regulation of multicellular organismal process | APP, AXL, BCL2, CA2, CHRNA7, CYP1B1, EGFR, ESRRB, F3, HMGCR, HSPA1A, KDR, MET, PIM1, SLC1A1, SMAD3, SRC, TEK | 2.74504 |
[BP] GO:0003006 | developmental process involved in reproduction | ALPL, AXL, BCL2, CDC25B, CYP19A1, EGFR, ESR1, ESRRB, HSD17B2, INSR, SRC | 2.74504 |
[BP] GO:0035239 | tube morphogenesis | BCL2, EDNRA, EGFR, ESR1, MET, SMAD3, SRC | 2.74504 |
[BP] GO:0032872 | regulation of stress-activated MAPK cascade | APP, DUSP3, EGFR, HMGCR, IGF1R, PTPN1, XDH | 2.74504 |
[BP] GO:0032845 | None | ADORA1, BCL2, HMGCR, SRC, TNKS, TNKS2 | 2.74428 |
[BP] GO:0070302 | regulation of stress-activated protein kinase signaling cascade | APP, DUSP3, EGFR, HMGCR, IGF1R, PTPN1, XDH | 2.73536 |
[BP] GO:0055074 | calcium ion homeostasis | APP, BCL2, CHRNA7, EDNRA, ESR1, GPR35, GRM1, GRM5, SMAD3 | 2.72402 |
[BP] GO:0051049 | regulation of transport | ACHE, ADORA1, APP, AXL, BCL2, CA2, CA7, CHRNA3, CYP19A1, EGFR, GPR35, GRIK5, GRM5, HMGCR, HSPA1A, INSR, PPARA, PTPN1, SMAD3, SRC | 2.72182 |
[BP] GO:1903727 | positive regulation of phospholipid metabolic process | FABP3, FLT3, SRC, TEK | 2.70928 |
[BP] GO:0048545 | response to steroid hormone | ALPL, BCL2, CA2, EGFR, FLT3, HSD11B2, SRC | 2.70497 |
[BP] GO:0007169 | transmembrane receptor protein tyrosine kinase signaling pathway | AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, PTPN1, SRC, TEK | 2.6991 |
[BP] GO:1901575 | None | ACHE, ADORA1, AKR1B10, ALDH2, AOX1, AURKB, CYP19A1, CYP1A1, CYP1A2, CYP1B1, FABP3, FABP4, FUT7, GAA, GBA2, HSPA1A, MGAM, XDH | 2.69051 |
[BP] GO:0072503 | cellular divalent inorganic cation homeostasis | APP, BCL2, CHRNA7, EDNRA, ESR1, GPR35, GRM1, GRM5, SMAD3 | 2.69051 |
[BP] GO:0010638 | positive regulation of organelle organization | AURKB, BCL2, HSPA1A, INSR, KDR, MET, SMAD3, SRC, TEK, TNKS, TNKS2 | 2.66211 |
[BP] GO:0001954 | positive regulation of cell-matrix adhesion | CDK6, KDR, SMAD3, TEK | 2.64268 |
[BP] GO:0030540 | female genitalia development | AXL, CYP19A1, ESR1 | 2.61115 |
[BP] GO:0051246 | regulation of protein metabolic process | ADORA1, APP, BCL2, CDC25B, CHRNA3, CHRNA7, CSNK2A1, DUSP3, EGFR, ESR1, F3, FABP4, FLT3, GRM1, GRM5, HMGCR, HSPA1A, IGF1R, INSR, KDR, NUAK1, PTPN1, SMAD3, SRC, TEK, XDH | 2.61027 |
[BP] GO:0032147 | activation of protein kinase activity | ADORA1, CHRNA3, CHRNA7, EGFR, GRM1, INSR, PTPN1, SRC | 2.60567 |
[BP] GO:2000026 | regulation of multicellular organismal development | APP, AXL, BCL2, CA2, CDK6, CHRNA3, CHRNA7, CYP1B1, EGFR, ESR1, ESRRA, F3, HMGCR, INSR, KDR, PIM1, SMAD3, SRC, TEK, XDH | 2.59803 |
[BP] GO:0010648 | negative regulation of cell communication | ACHE, ADORA1, BCL2, DUSP3, EGFR, ESR1, ESR2, GPR35, HMGCR, HSPA1A, IGF1R, MET, PTPN1, SMAD3, SRC, XDH | 2.59803 |
[BP] GO:0031960 | response to corticosteroid | ALPL, BCL2, EGFR, FLT3, HSD11B2, SRC | 2.597 |
[BP] GO:0003018 | None | ADORA1, EDNRA, EGFR, HMGCR, SRC, TEK | 2.597 |
[BP] GO:1902532 | negative regulation of intracellular signal transduction | BCL2, DUSP3, ESR1, HMGCR, HSPA1A, IGF1R, MET, PTPN1, SRC, XDH | 2.5916 |
[BP] GO:0023057 | negative regulation of signaling | ACHE, ADORA1, BCL2, DUSP3, EGFR, ESR1, ESR2, GPR35, HMGCR, HSPA1A, IGF1R, MET, PTPN1, SMAD3, SRC, XDH | 2.58772 |
[BP] GO:0050730 | None | ADORA1, APP, EGFR, FLT3, GRM5, PTPN1, SRC | 2.58471 |
[BP] GO:0018193 | peptidyl-amino acid modification | AURKB, AXL, BCL2, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, MET, SRC, TEK, TNKS | 2.57577 |
[BP] GO:0060255 | regulation of macromolecule metabolic process | ACHE, ADORA1, ADORA3, APP, AURKB, BCL2, CA9, CDC25B, CDK6, CHRNA3, CHRNA7, CSNK2A1, CYP1A2, CYP1B1, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP4, FLT3, GRM1, GRM5, HMGCR, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, PPARA, PTPN1, RORC, SMAD3, SRC, TEK, TNKS, TNKS2, XDH | 2.55211 |
[BP] GO:0010906 | None | ESRRB, INSR, PPARA, RORC, SRC | 2.55211 |
[BP] GO:1904355 | positive regulation of telomere capping | AURKB, TNKS, TNKS2 | 2.55211 |
[BP] GO:0006367 | transcription initiation from RNA polymerase II promoter | ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC | 2.53599 |
[BP] GO:0033559 | unsaturated fatty acid metabolic process | ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1 | 2.53447 |
[BP] GO:0065007 | biological regulation | ACHE, ADORA1, ADORA3, AKR1B1, APP, AURKB, AXL, BCL2, CA1, CA12, CA2, CA7, CA9, CDC25B, CDK6, CHRNA3, CHRNA7, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DUSP3, EDNRA, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, GAA, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, PPARA, PTPN1, RORC, SLC1A1, SMAD3, SRC, TEK, TNKS, TNKS2, XDH | 2.51837 |
[BP] GO:0022900 | electron transport chain | AKR1B1, ALDH2, AOX1, CYP19A1, CYP1A2, XDH | 2.51351 |
[BP] GO:0051726 | regulation of cell cycle | APP, AURKB, BCL2, CDC25B, CDK6, CSNK2A1, CYP1A1, DUSP3, EGFR, HSPA1A, INSR, PIM1, SMAD3, SRC, TNKS | 2.51351 |
[BP] GO:0051130 | positive regulation of cellular component organization | APP, AURKB, AXL, BCL2, ESR1, HSPA1A, IGF1R, INSR, KDR, MET, SMAD3, SRC, TEK, TNKS, TNKS2 | 2.49833 |
[BP] GO:0080135 | regulation of cellular response to stress | APP, CDK6, DUSP3, EGFR, HMGCR, HSPA1A, IGF1R, MET, NUAK1, PTPN1, XDH | 2.49833 |
[BP] GO:0099566 | None | GRM1, GRM5 | 2.49833 |
[BP] GO:0000023 | None | GAA, MGAM | 2.49833 |
[BP] GO:0046110 | None | AOX1, XDH | 2.49833 |
[BP] GO:0032849 | positive regulation of cellular pH reduction | CA2, CA7 | 2.49833 |
[BP] GO:1905144 | None | CHRNA3, CHRNA7 | 2.49833 |
[BP] GO:0016137 | None | AKR1B1, AKR1B10, GBA2 | 2.49833 |
[BP] GO:0009653 | anatomical structure morphogenesis | APP, AXL, BCL2, CA2, CA9, CHRNA7, CYP1B1, EDNRA, EGFR, ESR1, GAA, INSR, MET, SMAD3, SRC, TEK | 2.49368 |
[BP] GO:0048732 | gland development | BCL2, CSNK2A1, CYP19A1, EGFR, INSR, SMAD3, TYR | 2.49368 |
[BP] GO:0051828 | entry into other organism involved in symbiotic interaction | AXL, EGFR, HSPA1A, MET, SRC | 2.48189 |
[BP] GO:0051806 | entry into cell of other organism involved in symbiotic interaction | AXL, EGFR, HSPA1A, MET, SRC | 2.48189 |
[BP] GO:0030260 | entry into host cell | AXL, EGFR, HSPA1A, MET, SRC | 2.48189 |
[BP] GO:0044409 | entry into host | AXL, EGFR, HSPA1A, MET, SRC | 2.48189 |
[BP] GO:0009991 | response to extracellular stimulus | ALPL, AXL, BCL2, CYP1A1, EGFR, HMGCR, HSD11B2, SRC, TYR | 2.48189 |
[BP] GO:0072593 | reactive oxygen species metabolic process | BCL2, CYP1A1, CYP1A2, CYP1B1, EGFR | 2.46323 |
[BP] GO:0010676 | None | ESRRB, INSR, PPARA, SRC | 2.45731 |
[BP] GO:0006820 | anion transport | CA1, CA12, CA14, CA2, CA4, CA7, CA9, FABP3, PPARA, SLC1A1 | 2.45263 |
[BP] GO:0055065 | metal ion homeostasis | APP, BCL2, CHRNA7, EDNRA, EGFR, ESR1, GPR35, GRM1, GRM5, SMAD3 | 2.45263 |
[BP] GO:0032101 | regulation of response to external stimulus | ADORA1, CYP19A1, EGFR, ESR1, F3, FABP4, HMGCR, KDR, MET, PPARA, SMAD3, TEK | 2.45263 |
[BP] GO:2000377 | regulation of reactive oxygen species metabolic process | BCL2, CYP1B1, EGFR, INSR, SMAD3, XDH | 2.44783 |
[BP] GO:0051900 | regulation of mitochondrial depolarization | BCL2, KDR, SRC | 2.44783 |
[BP] GO:0032210 | regulation of telomere maintenance via telomerase | AURKB, SRC, TNKS, TNKS2 | 2.43611 |
[BP] GO:0006690 | icosanoid metabolic process | ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1 | 2.43611 |
[BP] GO:0008610 | lipid biosynthetic process | ACHE, AKR1B1, CSNK2A1, CYP19A1, CYP1A1, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2 | 2.41332 |
[BP] GO:0006979 | response to oxidative stress | AKR1B1, APP, AXL, BCL2, CYP1B1, EGFR, HSPA1A, SRC | 2.41332 |
[BP] GO:0051098 | regulation of binding | APP, AURKB, BCL2, MET, PPARA, SMAD3, SRC, TNKS | 2.41332 |
[BP] GO:0051893 | regulation of focal adhesion assembly | KDR, SMAD3, SRC, TEK | 2.41332 |
[BP] GO:0019369 | arachidonic acid metabolic process | CBR1, CYP1A1, CYP1A2, CYP1B1 | 2.41332 |
[BP] GO:0090109 | regulation of cell-substrate junction assembly | KDR, SMAD3, SRC, TEK | 2.41332 |
[BP] GO:0051128 | regulation of cellular component organization | APP, AURKB, AXL, BCL2, CHRNA3, CHRNA7, CSNK2A1, EGFR, ESR1, ESR2, GRIK5, HSPA1A, IGF1R, INSR, KDR, MET, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2 | 2.40973 |
[BP] GO:0007167 | enzyme linked receptor protein signaling pathway | AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, PTPN1, SMAD3, SRC, TEK | 2.39399 |
[BP] GO:0000302 | response to reactive oxygen species | AKR1B1, AXL, BCL2, CYP1B1, EGFR, SRC | 2.39399 |
[BP] GO:0006721 | terpenoid metabolic process | AKR1B10, CYP1A1, CYP1A2, CYP1B1, EGFR | 2.39125 |
[BP] GO:0042542 | response to hydrogen peroxide | AKR1B1, AXL, BCL2, CYP1B1, SRC | 2.37451 |
[BP] GO:0034614 | cellular response to reactive oxygen species | AKR1B1, AXL, CYP1B1, EGFR, SRC | 2.37451 |
[BP] GO:0071902 | positive regulation of protein serine/threonine kinase activity | ADORA1, CHRNA7, EGFR, FLT3, GRM1, INSR, PTPN1, SRC | 2.35348 |
[BP] GO:0019373 | epoxygenase P450 pathway | CYP1A1, CYP1A2, CYP1B1 | 2.33576 |
[BP] GO:1903391 | regulation of adherens junction organization | KDR, SMAD3, SRC, TEK | 2.33445 |
[BP] GO:1901564 | organonitrogen compound metabolic process | ACHE, AKR1B1, ALPL, AOX1, APP, AURKB, AXL, BCL2, CDC25B, CDK6, CSNK2A1, CYP1A1, CYP1A2, DUSP3, EGFR, ESR1, F3, FLT3, FUT7, GBA2, HMGCR, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, PPARA, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, TYR, XDH | 2.32547 |
[BP] GO:0044248 | cellular catabolic process | ACHE, AKR1B10, ALDH2, AOX1, AURKB, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, FABP3, FABP4, GAA, GBA2, HSPA1A, MGAM, SRC, XDH | 2.30699 |
[BP] GO:0030520 | intracellular estrogen receptor signaling pathway | ESR1, ESR2, SRC | 2.28165 |
[BP] GO:0034502 | protein localization to chromosome | AURKB, ESR1, TNKS, TNKS2 | 2.28165 |
[BP] GO:0001775 | cell activation | ALOX5, APP, AXL, BCL2, EGFR, FLT3, FUT7, GAA, HSPA1A, MGAM, RORC, SMAD3, SRC | 2.27044 |
[BP] GO:0050728 | negative regulation of inflammatory response | ADORA1, CYP19A1, PPARA, SMAD3, TEK | 2.26738 |
[BP] GO:0070213 | None | TNKS, TNKS2 | 2.26738 |
[BP] GO:0006145 | None | AOX1, XDH | 2.26738 |
[BP] GO:0018894 | dibenzo-p-dioxin metabolic process | CYP1A1, CYP1A2 | 2.26738 |
[BP] GO:1904356 | regulation of telomere maintenance via telomere lengthening | AURKB, SRC, TNKS, TNKS2 | 2.26738 |
[BP] GO:0048608 | reproductive structure development | AXL, BCL2, CYP19A1, ESR1, HSD17B2, INSR, SRC | 2.26338 |
[BP] GO:0050890 | None | ADORA1, APP, CHRNA7, EGFR, GRM5, HMGCR, INSR | 2.24458 |
[BP] GO:0010810 | regulation of cell-substrate adhesion | BCL2, CDK6, KDR, SMAD3, SRC, TEK | 2.2439 |
[BP] GO:0045935 | positive regulation of nucleobase-containing compound metabolic process | APP, AURKB, EGFR, ESR1, ESR2, ESRRA, ESRRB, HSPA1A, IGF1R, INSR, MET, PPARA, PTPN1, RORC, SMAD3, SRC, TNKS, TNKS2 | 2.2439 |
[BP] GO:0009404 | toxin metabolic process | CYP1A1, CYP1A2, CYP1B1 | 2.2439 |
[BP] GO:0045787 | positive regulation of cell cycle | APP, AURKB, CDC25B, CYP1A1, DUSP3, EGFR, INSR, SRC | 2.22232 |
[BP] GO:0051094 | positive regulation of developmental process | APP, AXL, BCL2, CA2, CHRNA7, CYP1B1, ESRRB, F3, HMGCR, INSR, KDR, PIM1, SMAD3, SRC, TEK | 2.22033 |
[BP] GO:0045936 | None | DUSP3, EDNRA, FABP4, GRM3, GRM8, HMGCR, IGF1R, PPARA, PTPN1, XDH | 2.214 |
[BP] GO:0010563 | None | DUSP3, EDNRA, FABP4, GRM3, GRM8, HMGCR, IGF1R, PPARA, PTPN1, XDH | 2.20913 |
[BP] GO:0051894 | None | KDR, SMAD3, TEK | 2.19746 |
[BP] GO:1903409 | reactive oxygen species biosynthetic process | CYP1A1, CYP1A2, CYP1B1 | 2.19746 |
[BP] GO:0010564 | regulation of cell cycle process | APP, AURKB, BCL2, CDC25B, CDK6, CSNK2A1, CYP1A1, EGFR, HSPA1A, INSR, TNKS | 2.19468 |
[BP] GO:0048754 | branching morphogenesis of an epithelial tube | BCL2, EDNRA, ESR1, MET, SRC | 2.18913 |
[BP] GO:0010675 | None | ESRRB, INSR, PPARA, RORC, SRC | 2.18913 |
[BP] GO:0034599 | cellular response to oxidative stress | AKR1B1, AXL, CYP1B1, EGFR, HSPA1A, SRC | 2.18699 |
[BP] GO:2000573 | positive regulation of DNA biosynthetic process | AURKB, SRC, TNKS, TNKS2 | 2.18171 |
[BP] GO:0006875 | cellular metal ion homeostasis | APP, BCL2, CHRNA7, EDNRA, ESR1, GPR35, GRM1, GRM5, SMAD3 | 2.18112 |
[BP] GO:0035690 | cellular response to drug | AKR1B1, AXL, CDK6, CYP1B1, EGFR, KDR, SRC | 2.16998 |
[BP] GO:0045834 | positive regulation of lipid metabolic process | FABP3, FLT3, PPARA, SRC, TEK | 2.16116 |
[BP] GO:0050927 | None | F3, KDR, SMAD3 | 2.15437 |
[BP] GO:0050727 | regulation of inflammatory response | ADORA1, CYP19A1, EGFR, ESR1, FABP4, PPARA, SMAD3, TEK | 2.11002 |
[BP] GO:0007154 | None | ADORA1, AXL, BCL2, CHRNA3, ESR2, GRIA2, GRIK5, GRM1, GRM3, GRM5, SLC1A1, TEK | 2.11002 |
[BP] GO:0050926 | None | F3, KDR, SMAD3 | 2.11002 |
[BP] GO:1904353 | regulation of telomere capping | AURKB, TNKS, TNKS2 | 2.11002 |
[BP] GO:1903393 | None | KDR, SMAD3, TEK | 2.11002 |
[BP] GO:0006811 | None | CA1, CA12, CA14, CA2, CA4, CA7, CA9, CHRNA3, CHRNA7, FABP3, GRIA2, GRIA4, GRIK5, PPARA, SLC1A1 | 2.09604 |
[BP] GO:0045913 | None | ESRRB, INSR, PPARA, SRC | 2.09409 |
[BP] GO:0007268 | None | CHRNA3, GRIA2, GRIK5, GRM1, GRM3, GRM5, SLC1A1 | 2.09409 |
[BP] GO:0098916 | None | CHRNA3, GRIA2, GRIK5, GRM1, GRM3, GRM5, SLC1A1 | 2.09409 |
[BP] GO:0043696 | None | CDK6, ESRRB | 2.09409 |
[BP] GO:0043697 | None | CDK6, ESRRB | 2.09409 |
[BP] GO:0010641 | None | F3, SRC | 2.09409 |
[BP] GO:0006352 | DNA-templated transcription, initiation | ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC | 2.08336 |
[BP] GO:0003013 | None | ADORA1, EDNRA, EGFR, HMGCR, SRC, TEK | 2.08336 |
[BP] GO:0043393 | regulation of protein binding | APP, AURKB, BCL2, MET, PPARA, SRC | 2.08336 |
[BP] GO:0042180 | None | AKR1B1, AKR1B10, CYP19A1, HMGCR | 2.08148 |
[BP] GO:1904357 | None | SRC, TNKS, TNKS2 | 2.07713 |
[BP] GO:1904646 | cellular response to amyloid-beta | APP, GRM5, IGF1R | 2.07713 |
[BP] GO:0006631 | fatty acid metabolic process | ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, FABP3, PPARA | 2.06912 |
[BP] GO:0007267 | None | ADORA1, CHRNA3, ESR2, GRIA2, GRIK5, GRM1, GRM3, GRM5, SLC1A1, TEK | 2.06078 |
[BP] GO:1901653 | cellular response to peptide | AKR1B1, APP, GRM5, IGF1R, INSR, SRC | 2.05843 |
[BP] GO:2000021 | regulation of ion homeostasis | ADORA1, BCL2, CA2, CA7, KDR, SRC | 2.05843 |
[BP] GO:0099536 | None | CHRNA3, GRIA2, GRIK5, GRM1, GRM3, GRM5, SLC1A1 | 2.04841 |
[BP] GO:0099537 | None | CHRNA3, GRIA2, GRIK5, GRM1, GRM3, GRM5, SLC1A1 | 2.04841 |
[BP] GO:1900543 | None | EDNRA, GRM3, GRM8, PPARA | 2.04471 |
[BP] GO:0032989 | cellular component morphogenesis | APP, AXL, BCL2, CHRNA7, EGFR, MET, SRC, TEK | 2.04362 |
[BP] GO:0009891 | positive regulation of biosynthetic process | APP, AURKB, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, IGF1R, INSR, KDR, MET, PPARA, RORC, SMAD3, SRC, TNKS, TNKS2 | 2.03285 |
[BP] GO:0050877 | None | ADORA1, APP, CHRNA7, CYP1B1, EGFR, GAA, GRM1, GRM5, GRM8, HMGCR, INSR, TYR | 2.03285 |
[BP] GO:1903725 | regulation of phospholipid metabolic process | FABP3, FLT3, SRC, TEK | 2.02827 |
[BP] GO:0045980 | None | EDNRA, GRM3, GRM8, PPARA | 2.02827 |
[BP] GO:0031667 | response to nutrient levels | ALPL, BCL2, CYP1A1, EGFR, HMGCR, HSD11B2, SRC, TYR | 2.02136 |
[BP] GO:0044057 | None | ADORA1, ADORA3, CHRNA3, EGFR, GAA, GPR35, GRM1, SLC1A1, SMAD3 | 2.007 |
[BP] GO:0097061 | None | CHRNA7, IGF1R, INSR | 2.00395 |
[BP] GO:0031099 | regeneration | AXL, BCL2, CSNK2A1, EGFR, FLT3 | 2.00395 |
[CC] GO:0098590 | plasma membrane region | ADORA1, CA2, CA4, CA9, CHRNA3, CHRNA7, EGFR, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, INSR, MET, MGAM, SLC1A1, SRC, TEK | 6.39259 |
[CC] GO:0005886 | plasma membrane | ACHE, ADORA1, ADORA3, ALPL, APP, AXL, CA12, CA14, CA2, CA4, CA9, CHRNA3, CHRNA7, CSNK2A1, EDNRA, EGFR, ESR1, F3, FLT3, GAA, GBA2, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, IGF1R, INSR, KDR, MET, MGAM, PIM1, PTPN1, SLC1A1, SMAD3, SRC, TEK | 5.27546 |
[CC] GO:0044459 | plasma membrane part | ADORA1, ADORA3, APP, AXL, CA2, CA4, CA9, CHRNA3, CHRNA7, DUSP3, EDNRA, EGFR, F3, FLT3, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, IGF1R, INSR, KDR, MET, MGAM, SLC1A1, SRC, TEK | 5.11184 |
[CC] GO:0043235 | receptor complex | APP, CHRNA3, CHRNA7, EGFR, GRIA2, GRIA4, GRIK5, GRM1, IGF1R, INSR, SMAD3 | 4.94245 |
[CC] GO:0016020 | membrane | ACHE, ADORA1, ADORA3, ALOX5, ALPL, APP, AXL, BCL2, CA12, CA14, CA2, CA4, CA9, CHRNA3, CHRNA7, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, EDNRA, EGFR, ESR1, F3, FLT3, FUT7, GAA, GBA2, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HMGCR, HSD11B1, HSD11B2, HSD17B2, IGF1R, INSR, KDR, MET, MGAM, PIM1, PTPN1, SLC1A1, SMAD3, SRC, TEK, TNKS, TNKS2, TYR | 4.88688 |
[CC] GO:0044425 | membrane part | ACHE, ADORA1, ADORA3, ALPL, APP, AXL, BCL2, CA12, CA14, CA2, CA4, CA9, CHRNA3, CHRNA7, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DUSP3, EDNRA, EGFR, ESR1, F3, FLT3, FUT7, GBA2, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HMGCR, HSD11B1, HSD11B2, HSD17B2, IGF1R, INSR, KDR, MET, MGAM, PTPN1, SLC1A1, SRC, TEK, TYR | 4.23826 |
[CC] GO:0031226 | intrinsic component of plasma membrane | ADORA1, ADORA3, APP, AXL, CA4, EDNRA, F3, FLT3, GPR35, GRIA2, GRM1, GRM3, GRM5, GRM8, IGF1R, INSR, KDR, MET, SLC1A1, TEK | 4.02415 |
[CC] GO:0097060 | None | CHRNA3, CHRNA7, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8 | 3.63628 |
[CC] GO:0044456 | None | ACHE, ADORA1, APP, CHRNA3, CHRNA7, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, SRC | 3.46134 |
[CC] GO:0042734 | None | GRIK5, GRM1, GRM3, GRM5, GRM8 | 3.30939 |
[CC] GO:0098802 | None | CHRNA3, CHRNA7, GRIA2, GRIA4, GRIK5, GRM1, INSR | 3.23762 |
[CC] GO:0005887 | integral component of plasma membrane | ADORA1, ADORA3, APP, AXL, EDNRA, FLT3, GPR35, GRIA2, GRM1, GRM3, GRM5, GRM8, IGF1R, INSR, KDR, MET, SLC1A1, TEK | 3.1765 |
[CC] GO:0014069 | None | ADORA1, CHRNA3, GRIK5, GRM1, GRM3, GRM5, SRC | 2.93795 |
[CC] GO:0099572 | None | ADORA1, CHRNA3, GRIK5, GRM1, GRM3, GRM5, SRC | 2.93795 |
[CC] GO:0044464 | cell part | ACHE, ADORA1, ADORA3, AKR1B1, AKR1B10, ALDH2, ALOX5, ALPL, AOX1, APP, AURKB, AXL, BCL2, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CBR1, CDC25B, CDK6, CHRNA3, CHRNA7, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DUSP3, EDNRA, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, FUT7, GAA, GBA2, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSPA1A, IGF1R, INSR, KDR, MET, MGAM, NUAK1, PIM1, PPARA, PTPN1, RORC, SLC1A1, SMAD3, SRC, TEK, TNKS, TNKS2, TYR, XDH | 2.82847 |
[CC] GO:0045121 | membrane raft | APP, CHRNA3, CHRNA7, EGFR, INSR, KDR, SRC, TEK | 2.77851 |
[CC] GO:0098857 | membrane microdomain | APP, CHRNA3, CHRNA7, EGFR, INSR, KDR, SRC, TEK | 2.76371 |
[CC] GO:0098794 | None | ADORA1, APP, CHRNA7, GRIA2, GRIA4, GRM3 | 2.63401 |
[CC] GO:0005783 | None | ADORA1, APP, BCL2, CA4, CYP19A1, FLT3, GBA2, GRIK5, HMGCR, HSPA1A, KDR, PTPN1, XDH | 2.34107 |
[CC] GO:0043227 | membrane-bounded organelle | ACHE, ADORA1, AKR1B1, AKR1B10, ALDH2, ALPL, AOX1, APP, AURKB, AXL, BCL2, CA1, CA2, CA4, CBR1, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, FUT7, GAA, GBA2, GRIA4, GRIK5, GRM1, GRM5, HMGCR, HSPA1A, IGF1R, INSR, KDR, MGAM, NUAK1, PIM1, PPARA, PTPN1, RORC, SLC1A1, SMAD3, SRC, TNKS, TNKS2, TYR, XDH | 2.33486 |
[CC] GO:0098589 | membrane region | APP, CHRNA3, CHRNA7, EGFR, INSR, KDR, SRC, TEK | 2.33391 |
[CC] GO:0016323 | basolateral plasma membrane | ADORA1, CA2, CA4, CA9, EGFR, TEK | 2.26563 |
[CC] GO:0043197 | None | ADORA1, APP, GRIA2, GRIA4, GRM3 | 2.22808 |
[CC] GO:0044309 | None | ADORA1, APP, GRIA2, GRIA4, GRM3 | 2.19935 |
[CC] GO:0044432 | endoplasmic reticulum part | APP, BCL2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, EGFR, FLT3, GBA2, GRIA2, HMGCR, HSD11B1, HSD11B2, HSD17B2, PTPN1 | 2.1327 |
[CC] GO:0031224 | None | ACHE, ADORA1, ADORA3, ALPL, APP, AXL, CA12, CA14, CA4, CA9, CHRNA3, CHRNA7, EDNRA, EGFR, ESR1, F3, FLT3, FUT7, GBA2, GPR35, GRIA2, GRM1, GRM3, GRM5, GRM8, HMGCR, HSD11B1, HSD17B2, IGF1R, INSR, KDR, MET, MGAM, SLC1A1, TEK, TYR | 2.12006 |
[CC] GO:0043226 | organelle | ACHE, ADORA1, AKR1B1, AKR1B10, ALDH2, ALPL, AOX1, APP, AURKB, AXL, BCL2, CA1, CA2, CA4, CA9, CBR1, CDK6, CHRNA3, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, FUT7, GAA, GBA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, HMGCR, HSPA1A, IGF1R, INSR, KDR, MGAM, NUAK1, PIM1, PPARA, PTPN1, RORC, SLC1A1, SMAD3, SRC, TNKS, TNKS2, TYR, XDH | 2.06078 |
[CC] GO:0045211 | None | CHRNA3, CHRNA7, GRIA2, GRIA4, GRIK5, GRM3 | 2.03285 |
[MF] GO:0004089 | carbonate dehydratase activity | CA1, CA12, CA14, CA2, CA4, CA7, CA9 | 9.42526 |
[MF] GO:0038023 | signaling receptor activity | ADORA1, ADORA3, AXL, CHRNA3, CHRNA7, EDNRA, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, IGF1R, INSR, KDR, MET, PPARA, RORC, TEK | 9.34664 |
[MF] GO:0046914 | transition metal ion binding | ALOX5, AOX1, APP, CA1, CA12, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, PIM1, PPARA, PTPN1, RORC, SMAD3, TNKS, TYR, XDH | 9.24992 |
[MF] GO:0060089 | molecular transducer activity | ADORA1, ADORA3, AXL, CDK6, CHRNA3, CHRNA7, EDNRA, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, IGF1R, INSR, KDR, MET, PPARA, RORC, TEK | 8.70252 |
[MF] GO:0004872 | receptor activity | ADORA1, ADORA3, AXL, CHRNA3, CHRNA7, EDNRA, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, IGF1R, INSR, KDR, MET, PPARA, RORC, TEK | 8.3963 |
[MF] GO:0004871 | signal transducer activity | ADORA1, ADORA3, AXL, CHRNA3, CHRNA7, EDNRA, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, IGF1R, INSR, KDR, MET, PPARA, RORC, SMAD3, TEK | 8.29002 |
[MF] GO:0003824 | catalytic activity | ACHE, ADORA1, AKR1B1, AKR1B10, ALDH2, ALOX5, ALPL, AOX1, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CBR1, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DUSP3, EDNRA, EGFR, F3, FLT3, FUT7, GAA, GBA2, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSPA1A, IGF1R, INSR, KDR, MET, MGAM, NUAK1, PIM1, PTPN1, SRC, TEK, TNKS, TNKS2, TYR, XDH | 8.29002 |
[MF] GO:0008066 | None | GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8 | 8.013 |
[MF] GO:0004714 | transmembrane receptor protein tyrosine kinase activity | AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, TEK | 7.07467 |
[MF] GO:0016614 | oxidoreductase activity, acting on CH-OH group of donors | AKR1B1, AKR1B10, AOX1, CBR1, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2, XDH | 7.01411 |
[MF] GO:0043167 | ion binding | ACHE, ALOX5, ALPL, AOX1, APP, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CDK6, CHRNA3, CHRNA7, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, HMGCR, HSD17B1, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, PPARA, PTPN1, RORC, SLC1A1, SMAD3, SRC, TEK, TNKS, TNKS2, TYR, XDH | 6.64771 |
[MF] GO:0019199 | transmembrane receptor protein kinase activity | AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, TEK | 6.39149 |
[MF] GO:0099600 | transmembrane receptor activity | ADORA1, ADORA3, AXL, CHRNA3, CHRNA7, EDNRA, EGFR, F3, FLT3, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, IGF1R, INSR, KDR, MET, TEK | 6.1545 |
[MF] GO:0004888 | transmembrane signaling receptor activity | ADORA1, ADORA3, AXL, CHRNA3, CHRNA7, EDNRA, EGFR, F3, FLT3, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, IGF1R, INSR, KDR, MET, TEK | 6.1545 |
[MF] GO:0016836 | hydro-lyase activity | CA1, CA12, CA14, CA2, CA4, CA7, CA9 | 6.08638 |
[MF] GO:0016491 | oxidoreductase activity | AKR1B1, AKR1B10, ALDH2, ALOX5, AOX1, CBR1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2, TYR, XDH | 5.97467 |
[MF] GO:0016835 | carbon-oxygen lyase activity | CA1, CA12, CA14, CA2, CA4, CA7, CA9 | 5.26688 |
[MF] GO:0016616 | oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor | AKR1B1, AKR1B10, CBR1, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2 | 5.19377 |
[MF] GO:0098531 | transcription factor activity, direct ligand regulated sequence-specific DNA binding | ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC | 5.0229 |
[MF] GO:0004879 | nuclear receptor activity | ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC | 5.0229 |
[MF] GO:0004713 | protein tyrosine kinase activity | AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, SRC, TEK | 5.0229 |
[MF] GO:0042562 | hormone binding | ACHE, CHRNA3, CHRNA7, EGFR, HSD17B1, IGF1R, INSR | 4.98842 |
[MF] GO:0005496 | steroid binding | ESR1, ESR2, ESRRA, ESRRB, HSD11B2, HSD17B1, RORC | 4.97119 |
[MF] GO:0008144 | drug binding | ACHE, AURKB, AXL, CDK6, CHRNA3, CHRNA7, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, EGFR, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, PPARA, SRC, TEK | 4.67885 |
[MF] GO:0003707 | steroid hormone receptor activity | ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC | 4.66247 |
[MF] GO:0004672 | protein kinase activity | AURKB, AXL, CDK6, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK | 4.41936 |
[MF] GO:0030594 | None | CHRNA3, CHRNA7, GRIA2, GRIA4, GRIK5, GRM1, GRM5 | 4.40267 |
[MF] GO:0008270 | zinc ion binding | CA1, CA12, CA2, CA4, CA7, CA9, ESR1, ESR2, ESRRA, ESRRB, PPARA, PTPN1, RORC, SMAD3, TNKS | 4.1107 |
[MF] GO:0016903 | None | AKR1B1, AKR1B10, ALDH2, AOX1, XDH | 3.95207 |
[MF] GO:0005231 | None | CHRNA3, CHRNA7, GRIA2, GRIA4, GRIK5 | 3.77732 |
[MF] GO:0098960 | None | CHRNA3, CHRNA7, GRM1, GRM5 | 3.77431 |
[MF] GO:0022824 | None | CHRNA3, CHRNA7, GRIA2, GRIA4, GRIK5 | 3.70736 |
[MF] GO:0022835 | None | CHRNA3, CHRNA7, GRIA2, GRIA4, GRIK5 | 3.70736 |
[MF] GO:0070330 | aromatase activity | CYP19A1, CYP1A1, CYP1A2, CYP1B1 | 3.63628 |
[MF] GO:0016773 | phosphotransferase activity, alcohol group as acceptor | AURKB, AXL, CDK6, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK | 3.60576 |
[MF] GO:0048037 | cofactor binding | ALDH2, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, HMGCR, HSD11B2, HSD17B1, SRC, XDH | 3.46933 |
[MF] GO:0016712 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen | CYP19A1, CYP1A1, CYP1A2, CYP1B1 | 3.44057 |
[MF] GO:0005506 | iron ion binding | ALOX5, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, XDH | 3.43441 |
[MF] GO:0036094 | small molecule binding | ADORA1, ALDH2, AOX1, AURKB, AXL, CDK6, CSNK2A1, EGFR, FABP3, FABP4, FLT3, HMGCR, HSD11B2, HSD17B1, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SLC1A1, SRC, TEK, XDH | 3.39595 |
[MF] GO:0033764 | steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor | HSD11B1, HSD11B2, HSD17B1, HSD17B2 | 3.38598 |
[MF] GO:0019902 | phosphatase binding | BCL2, EGFR, HMGCR, MET, PPARA, PTPN1, SMAD3 | 3.37475 |
[MF] GO:0009055 | electron transfer activity | AKR1B1, ALDH2, AOX1, CYP19A1, CYP1A2, XDH | 3.33272 |
[MF] GO:0004716 | signal transducer, downstream of receptor, with protein tyrosine kinase activity | EGFR, INSR, KDR | 3.27876 |
[MF] GO:0016229 | steroid dehydrogenase activity | HSD11B1, HSD11B2, HSD17B1, HSD17B2 | 3.27706 |
[MF] GO:0016301 | kinase activity | AURKB, AXL, CDK6, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK | 3.23523 |
[MF] GO:0016829 | lyase activity | CA1, CA12, CA14, CA2, CA4, CA7, CA9 | 3.10474 |
[MF] GO:0043169 | cation binding | ACHE, ALOX5, ALPL, AOX1, APP, AURKB, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CHRNA3, CHRNA7, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, NUAK1, PIM1, PPARA, PTPN1, RORC, SLC1A1, SMAD3, TNKS, TNKS2, TYR, XDH | 3.07923 |
[MF] GO:0005230 | None | CHRNA3, CHRNA7, GRIA2, GRIA4, GRIK5 | 2.97283 |
[MF] GO:0008289 | lipid binding | AXL, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, HSD11B2, HSD17B1, PPARA, RORC | 2.94726 |
[MF] GO:0038052 | RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding | ESR1, ESR2 | 2.87243 |
[MF] GO:0003845 | None | HSD11B1, HSD11B2 | 2.87243 |
[MF] GO:0015926 | None | GAA, GBA2, MGAM | 2.76371 |
[MF] GO:0019899 | enzyme binding | APP, AURKB, BCL2, CDC25B, CYP1A1, CYP1A2, DUSP3, EGFR, ESR1, ESR2, ESRRB, F3, GRM5, HMGCR, HSPA1A, MET, PPARA, PTPN1, SMAD3, SRC, TEK, TNKS2 | 2.7293 |
[MF] GO:0044877 | macromolecular complex binding | ACHE, ADORA1, CSNK2A1, EGFR, ESRRB, FLT3, IGF1R, INSR, KDR, PIM1, PPARA, PTPN1, SMAD3, SRC | 2.66211 |
[MF] GO:0019825 | oxygen binding | CYP19A1, CYP1A1, CYP1A2, CYP1B1 | 2.64268 |
[MF] GO:0016772 | transferase activity, transferring phosphorus-containing groups | AURKB, AXL, CDK6, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK | 2.57158 |
[MF] GO:0004497 | monooxygenase activity | CYP19A1, CYP1A1, CYP1A2, CYP1B1, TYR | 2.56922 |
[MF] GO:0042166 | None | ACHE, CHRNA3, CHRNA7 | 2.55211 |
[MF] GO:0000166 | nucleotide binding | ALDH2, AOX1, AURKB, AXL, CDK6, CSNK2A1, EGFR, FLT3, HMGCR, HSD11B2, HSD17B1, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK, XDH | 2.52123 |
[MF] GO:1901265 | nucleoside phosphate binding | ALDH2, AOX1, AURKB, AXL, CDK6, CSNK2A1, EGFR, FLT3, HMGCR, HSD11B2, HSD17B1, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK, XDH | 2.51961 |
[MF] GO:0032450 | None | GAA, MGAM | 2.49833 |
[MF] GO:0099583 | None | GRM1, GRM5 | 2.49833 |
[MF] GO:0042802 | identical protein binding | ACHE, AOX1, APP, BCL2, CHRNA7, CSNK2A1, EGFR, ESR1, ESR2, FLT3, GRIK5, HMGCR, IGF1R, KDR, MET, SMAD3, TYR, XDH | 2.49219 |
[MF] GO:0004970 | None | GRIA2, GRIA4, GRIK5 | 2.44783 |
[MF] GO:0005234 | None | GRIA2, GRIA4, GRIK5 | 2.44783 |
[MF] GO:0032403 | protein complex binding | ACHE, ADORA1, EGFR, ESRRB, FLT3, IGF1R, INSR, KDR, PPARA, PTPN1, SMAD3, SRC | 2.41332 |
[MF] GO:0043168 | anion binding | AOX1, APP, AURKB, AXL, CDK6, CSNK2A1, EGFR, F3, FABP3, FABP4, FLT3, HMGCR, HSD17B1, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SLC1A1, SRC, TEK, XDH | 2.27285 |
[MF] GO:0034056 | estrogen response element binding | ESR1, ESR2 | 2.26738 |
[MF] GO:0004971 | None | GRIA2, GRIA4 | 2.26738 |
[MF] GO:0051425 | None | APP, INSR | 2.26738 |
[MF] GO:0004558 | None | GAA, MGAM | 2.26738 |
[MF] GO:0001540 | amyloid-beta binding | ACHE, CHRNA7, GRIA2, INSR | 2.26738 |
[MF] GO:0019903 | protein phosphatase binding | BCL2, EGFR, HMGCR, MET, PTPN1 | 2.22808 |
[MF] GO:0046872 | metal ion binding | ALOX5, ALPL, AOX1, APP, AURKB, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, NUAK1, PIM1, PPARA, PTPN1, RORC, SLC1A1, SMAD3, TNKS, TNKS2, TYR, XDH | 2.18913 |
[MF] GO:0020037 | heme binding | CYP19A1, CYP1A1, CYP1A2, CYP1B1, SRC | 2.09409 |
[MF] GO:0030284 | estrogen receptor activity | ESR1, ESR2 | 2.09409 |
[MF] GO:0043559 | insulin binding | IGF1R, INSR | 2.09409 |
[MF] GO:0019838 | growth factor binding | EGFR, IGF1R, INSR, KDR, TEK | 2.07514 |
[MF] GO:0051721 | None | BCL2, HMGCR, PTPN1 | 2.04047 |
[MF] GO:0043548 | phosphatidylinositol 3-kinase binding | AXL, IGF1R, INSR | 2.00395 |
KEGG Pathway ID | Enriched Genes | Log10 Adjusted P-value |
---|---|---|
Ovarian steroidogenesis_Homo sapiens_hsa04913 | ALOX5, INSR, HSD17B1, HSD17B2, CYP1A1, CYP1B1, CYP19A1, IGF1R | 8.9252 |
Nitrogen metabolism_Homo sapiens_hsa00910 | CA12, CA1, CA2, CA4, CA7, CA9, CA14 | 10.561 |
Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | GRIA2, CHRNA3, GPR35, CHRNA7, GRIK5, GRM1, GRM3, GRM5, EDNRA, ADORA3, GRM8, ADORA1, GRIA4 | 8.6863 |
Steroid hormone biosynthesis_Homo sapiens_hsa00140 | HSD11B1, HSD11B2, HSD17B1, HSD17B2, CYP1A2, CYP1A1, CYP1B1, CYP19A1 | 8.684 |
Adherens junction_Homo sapiens_hsa04520 | PTPN1, SMAD3, CSNK2A1, SRC, INSR, MET, EGFR, IGF1R | 7.9066 |
Glutamatergic synapse_Homo sapiens_hsa04724 | GRM3, GRIA2, GRM5, GRIK5, GRM8, SLC1A1, GRM1, GRIA4 | 6.4757 |
Metabolic pathways_Homo sapiens_hsa01100 | CBR1, MGAM, GAA, AKR1B1, HMGCR, TYR, GBA2, CYP19A1, HSD11B1, FUT7, AKR1B10, ALDH2, ALOX5, HSD17B1, HSD17B2, CYP1A2, CYP1A1, AOX1, ALPL, XDH | 6.2532 |
Tryptophan metabolism_Homo sapiens_hsa00380 | ALDH2, CYP1A2, CYP1A1, AOX1, CYP1B1 | 5.0612 |
Estrogen signaling pathway_Homo sapiens_hsa04915 | SRC, ESR1, GRM1, EGFR, ESR2, HSPA1A | 4.4528 |
Chemical carcinogenesis_Homo sapiens_hsa05204 | HSD11B1, CBR1, CHRNA7, CYP1A2, CYP1A1, CYP1B1 | 4.8901 |
Rap1 signaling pathway_Homo sapiens_hsa04015 | SRC, INSR, KDR, TEK, MET, EGFR, IGF1R | 3.6946 |
Phospholipase D signaling pathway_Homo sapiens_hsa04072 | GRM3, GRM5, INSR, GRM8, GRM1, EGFR | 3.66 |
Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | HSD11B1, CBR1, CYP1A2, CYP1A1, CYP1B1 | 3.9212 |
PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | CDK6, INSR, KDR, BCL2, TEK, MET, EGFR, IGF1R | 3.319 |
Endocytosis_Homo sapiens_hsa04144 | SMAD3, SRC, KDR, MET, EGFR, IGF1R, HSPA1A | 3.2428 |
HIF-1 signaling pathway_Homo sapiens_hsa04066 | INSR, BCL2, TEK, EGFR, IGF1R | 3.319 |
Pathways in cancer_Homo sapiens_hsa05200 | EDNRA, CDK6, SMAD3, FLT3, BCL2, MET, EGFR, IGF1R | 2.9642 |
Proteoglycans in cancer_Homo sapiens_hsa05205 | SRC, KDR, MET, ESR1, EGFR, IGF1R | 2.9642 |
Focal adhesion_Homo sapiens_hsa04510 | SRC, KDR, BCL2, MET, EGFR, IGF1R | 2.9642 |
Galactose metabolism_Homo sapiens_hsa00052 | MGAM, AKR1B10, GAA, AKR1B1 | 4.1238 |
MicroRNAs in cancer_Homo sapiens_hsa05206 | CDK6, BCL2, PIM1, CYP1B1, MET, EGFR, CDC25B | 2.9642 |
Ras signaling pathway_Homo sapiens_hsa04014 | INSR, KDR, TEK, MET, EGFR, IGF1R | 2.8167 |
FoxO signaling pathway_Homo sapiens_hsa04068 | SMAD3, INSR, GRM1, EGFR, IGF1R | 2.9642 |
Melanoma_Homo sapiens_hsa05218 | CDK6, MET, EGFR, IGF1R | 2.9642 |
AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | SMAD3, BCL2, PIM1, F3 | 2.4748 |
Calcium signaling pathway_Homo sapiens_hsa04020 | GRM5, EDNRA, CHRNA7, GRM1, EGFR | 2.4742 |
Cholinergic synapse_Homo sapiens_hsa04725 | ACHE, CHRNA3, CHRNA7, BCL2 | 2.3489 |
Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | GRIA2, GRM5, GRM1, GRIA4 | 2.4748 |
Gap junction_Homo sapiens_hsa04540 | GRM5, SRC, GRM1, EGFR | 2.6562 |
cAMP signaling pathway_Homo sapiens_hsa04024 | GRIA2, EDNRA, ADORA1, PPARA, GRIA4 | 2.3053 |
Hepatitis B_Homo sapiens_hsa05161 | CDK6, SMAD3, SRC, BCL2 | 2.0585 |
Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | FABP4, INSR, ADORA1 | 2.2016 |
Glioma_Homo sapiens_hsa05214 | CDK6, EGFR, IGF1R | 2.077 |
Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | INSR, IGF1R, HSPA1A | 2.077 |
cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | EDNRA, ADORA3, INSR, ADORA1 | 1.8768 |
Long-term depression_Homo sapiens_hsa04730 | GRIA2, GRM1, IGF1R | 2.1397 |
Glycerolipid metabolism_Homo sapiens_hsa00561 | AKR1B10, ALDH2, AKR1B1 | 2.1485 |
Pancreatic cancer_Homo sapiens_hsa05212 | CDK6, SMAD3, EGFR | 2.077 |
Long-term potentiation_Homo sapiens_hsa04720 | GRIA2, GRM5, GRM1 | 2.077 |
Nicotine addiction_Homo sapiens_hsa05033 | GRIA2, CHRNA7, GRIA4 | 2.5464 |
Central carbon metabolism in cancer_Homo sapiens_hsa05230 | FLT3, MET, EGFR | 2.0687 |
Retinol metabolism_Homo sapiens_hsa00830 | CYP1A2, CYP1A1, AOX1 | 2.077 |
Prostate cancer_Homo sapiens_hsa05215 | BCL2, EGFR, IGF1R | 1.7867 |
Prolactin signaling pathway_Homo sapiens_hsa04917 | SRC, ESR1, ESR2 | 2.019 |
Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | SRC, MET, EGFR | 2.0606 |
Insulin resistance_Homo sapiens_hsa04931 | PTPN1, INSR, PPARA | 1.5691 |
Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | AKR1B10, ALDH2, AKR1B1 | 2.6562 |
Toxoplasmosis_Homo sapiens_hsa05145 | ALOX5, BCL2, HSPA1A | 1.4919 |
MAPK signaling pathway_Homo sapiens_hsa04010 | DUSP3, EGFR, CDC25B, HSPA1A | 1.3624 |
Sphingolipid signaling pathway_Homo sapiens_hsa04071 | ADORA3, BCL2, ADORA1 | 1.4878 |
PPAR signaling pathway_Homo sapiens_hsa03320 | FABP3, FABP4, PPARA | 2.0585 |
AMPK signaling pathway_Homo sapiens_hsa04152 | INSR, HMGCR, IGF1R | 1.4647 |
Measles_Homo sapiens_hsa05162 | CDK6, CSNK2A1, HSPA1A | 1.3793 |
Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | FLT3, KDR, MET, EGFR | 1.3209 |
Cell cycle_Homo sapiens_hsa04110 | CDK6, SMAD3, CDC25B | 1.4647 |
Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | SMAD3, ESRRB, IGF1R | 1.3506 |
Jak-STAT signaling pathway_Homo sapiens_hsa04630 | BCL2, PIM1, AOX1 | 1.2695 |
Epstein-Barr virus infection_Homo sapiens_hsa05169 | CSNK2A1, BCL2, HSPA1A | 1.0658 |
Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | FLT3, MET, IGF1R | 1.1772 |
HTLV-I infection_Homo sapiens_hsa05166 | SMAD3 | 0.2021 |
Huntington's disease_Homo sapiens_hsa05016 | GRM5 | 0.2797 |
Herpes simplex infection_Homo sapiens_hsa05168 | CSNK2A1 | 0.2871 |
Hepatitis C_Homo sapiens_hsa05160 | PPARA, EGFR | 0.7997 |
Purine metabolism_Homo sapiens_hsa00230 | XDH | 0.2996 |
Dopaminergic synapse_Homo sapiens_hsa04728 | GRIA2, GRIA4 | 0.813 |
Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | SRC, ESR1 | 0.8703 |
Chemokine signaling pathway_Homo sapiens_hsa04062 | SRC | 0.2864 |
Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | CDC25B, IGF1R | 0.997 |
Influenza A_Homo sapiens_hsa05164 | HSPA1A | 0.2996 |
GnRH signaling pathway_Homo sapiens_hsa04912 | SRC, EGFR | 1.0297 |
Insulin signaling pathway_Homo sapiens_hsa04910 | PTPN1, INSR | 0.7934 |
Alzheimer's disease_Homo sapiens_hsa05010 | APP | 0.3086 |
Serotonergic synapse_Homo sapiens_hsa04726 | APP, ALOX5 | 0.9048 |
Wnt signaling pathway_Homo sapiens_hsa04310 | SMAD3, CSNK2A1 | 0.782 |
Tight junction_Homo sapiens_hsa04530 | CSNK2A1, SRC | 0.7934 |
Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | BCL2, HSPA1A | 0.6942 |
Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | INSR, IGF1R | 1.0147 |
Hippo signaling pathway_Homo sapiens_hsa04390 | SMAD3 | 0.3355 |
ErbB signaling pathway_Homo sapiens_hsa04012 | SRC, EGFR | 1.0597 |
Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | BCL2 | 0.3435 |
Circadian entrainment_Homo sapiens_hsa04713 | GRIA2, GRIA4 | 1.0114 |
Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | INSR, PPARA | 0.7622 |
Tuberculosis_Homo sapiens_hsa05152 | SRC, BCL2 | 0.6657 |
Apoptosis_Homo sapiens_hsa04210 | BCL2 | 0.3589 |
Oxytocin signaling pathway_Homo sapiens_hsa04921 | SRC, EGFR | 0.7338 |
Spliceosome_Homo sapiens_hsa03040 | HSPA1A | 0.3708 |
NF-kappa B signaling pathway_Homo sapiens_hsa04064 | CSNK2A1, BCL2 | 1.0179 |
Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | SRC, EGFR | 0.5882 |
Viral carcinogenesis_Homo sapiens_hsa05203 | CDK6, SRC | 0.6098 |
Lysosome_Homo sapiens_hsa04142 | GAA | 0.3942 |
Small cell lung cancer_Homo sapiens_hsa05222 | CDK6, BCL2 | 1.0635 |
Platelet activation_Homo sapiens_hsa04611 | SRC | 0.3942 |
Neurotrophin signaling pathway_Homo sapiens_hsa04722 | BCL2 | 0.3943 |
Axon guidance_Homo sapiens_hsa04360 | MET | 0.3861 |
Oocyte meiosis_Homo sapiens_hsa04114 | IGF1R | 0.3942 |
Chronic myeloid leukemia_Homo sapiens_hsa05220 | CDK6, SMAD3 | 1.1772 |
Vascular smooth muscle contraction_Homo sapiens_hsa04270 | EDNRA | 0.3943 |
Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | SRC, MET | 1.1299 |
VEGF signaling pathway_Homo sapiens_hsa04370 | SRC, KDR | 1.2695 |
Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | SMAD3 | 0.4385 |
Melanogenesis_Homo sapiens_hsa04916 | TYR | 0.4461 |
Choline metabolism in cancer_Homo sapiens_hsa05231 | EGFR | 0.4461 |
Glucagon signaling pathway_Homo sapiens_hsa04922 | PPARA | 0.4461 |
Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | SRC | 0.4482 |
Non-small cell lung cancer_Homo sapiens_hsa05223 | CDK6, EGFR | 1.3143 |
Glycerophospholipid metabolism_Homo sapiens_hsa00564 | ACHE | 0.4535 |
Pancreatic secretion_Homo sapiens_hsa04972 | CA2 | 0.4526 |
Amphetamine addiction_Homo sapiens_hsa05031 | GRIA2, GRIA4 | 1.2236 |
Acute myeloid leukemia_Homo sapiens_hsa05221 | FLT3, PIM1 | 1.3063 |
Morphine addiction_Homo sapiens_hsa05032 | ADORA1 | 0.4661 |
Rheumatoid arthritis_Homo sapiens_hsa05323 | TEK | 0.4671 |
Hematopoietic cell lineage_Homo sapiens_hsa04640 | FLT3 | 0.4671 |
Bile secretion_Homo sapiens_hsa04976 | CA2, HMGCR | 1.1884 |
GABAergic synapse_Homo sapiens_hsa04727 | SRC | 0.4671 |
Taste transduction_Homo sapiens_hsa04742 | GRM1 | 0.4783 |
TGF-beta signaling pathway_Homo sapiens_hsa04350 | SMAD3 | 0.477 |
Renin secretion_Homo sapiens_hsa04924 | EDNRA, ADORA1 | 1.249 |
Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | CYP1A2, AOX1 | 1.2057 |
Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | CSNK2A1 | 0.4671 |
Protein digestion and absorption_Homo sapiens_hsa04974 | SLC1A1 | 0.4671 |
Colorectal cancer_Homo sapiens_hsa05210 | SMAD3, BCL2 | 1.2687 |
Peroxisome_Homo sapiens_hsa04146 | XDH | 0.4783 |
Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | SMAD3, RORC | 1.2423 |
Complement and coagulation cascades_Homo sapiens_hsa04610 | F3 | 0.4904 |
Starch and sucrose metabolism_Homo sapiens_hsa00500 | MGAM, GAA | 1.3143 |
Antigen processing and presentation_Homo sapiens_hsa04612 | HSPA1A | 0.4968 |
Cocaine addiction_Homo sapiens_hsa05030 | GRM3, GRIA2 | 1.3793 |
Gastric acid secretion_Homo sapiens_hsa04971 | CA2 | 0.5085 |
Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | GRIA2, BCL2 | 1.3624 |
Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | ALDH2, AOX1 | 1.3858 |
Arachidonic acid metabolism_Homo sapiens_hsa00590 | CBR1, ALOX5 | 1.2687 |
Adipocytokine signaling pathway_Homo sapiens_hsa04920 | PPARA | 0.5262 |
Bladder cancer_Homo sapiens_hsa05219 | SRC, EGFR | 1.4878 |
Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | HSD11B2, INSR | 1.5123 |
p53 signaling pathway_Homo sapiens_hsa04115 | CDK6 | 0.5284 |
Renal cell carcinoma_Homo sapiens_hsa05211 | MET | 0.5387 |
Shigellosis_Homo sapiens_hsa05131 | SRC | 0.5412 |
Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | ALDH2 | 0.5363 |
Endometrial cancer_Homo sapiens_hsa05213 | EGFR | 0.6142 |
Legionellosis_Homo sapiens_hsa05134 | HSPA1A | 0.5991 |
Lysine degradation_Homo sapiens_hsa00310 | ALDH2 | 0.6142 |
Tyrosine metabolism_Homo sapiens_hsa00350 | AOX1, TYR | 1.5865 |
Malaria_Homo sapiens_hsa05144 | MET | 0.6271 |
Arginine and proline metabolism_Homo sapiens_hsa00330 | ALDH2 | 0.6227 |
Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | ESR1 | 0.6364 |
Type II diabetes mellitus_Homo sapiens_hsa04930 | INSR | 0.6317 |
Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | MGAM | 0.6426 |
Fructose and mannose metabolism_Homo sapiens_hsa00051 | AKR1B10, AKR1B1 | 1.6538 |
Drug metabolism - other enzymes_Homo sapiens_hsa00983 | XDH | 0.6377 |
Sphingolipid metabolism_Homo sapiens_hsa00600 | GBA2 | 0.6364 |
Fatty acid degradation_Homo sapiens_hsa00071 | ALDH2 | 0.648 |
Prion diseases_Homo sapiens_hsa05020 | HSPA1A | 0.7249 |
Pyruvate metabolism_Homo sapiens_hsa00620 | ALDH2 | 0.6786 |
Dorso-ventral axis formation_Homo sapiens_hsa04320 | EGFR | 0.7934 |
Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | CA2, CA4 | 1.9097 |
Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | FUT7 | 0.7627 |
Linoleic acid metabolism_Homo sapiens_hsa00591 | CYP1A2 | 0.7778 |
beta-Alanine metabolism_Homo sapiens_hsa00410 | ALDH2 | 0.7627 |
Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | AOX1 | 0.7778 |
Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | FUT7 | 0.7934 |
Circadian rhythm_Homo sapiens_hsa04710 | RORC | 0.768 |
Collecting duct acid secretion_Homo sapiens_hsa04966 | CA2 | 0.7934 |
Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | ALDH2 | 0.7934 |
Histidine metabolism_Homo sapiens_hsa00340 | ALDH2 | 0.813 |
Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | HMGCR | 0.8401 |
Other glycan degradation_Homo sapiens_hsa00511 | GBA2 | 0.9097 |
Folate biosynthesis_Homo sapiens_hsa00790 | ALPL | 1.0062 |
Caffeine metabolism_Homo sapiens_hsa00232 | CYP1A2, XDH | 2.9642 |
Vitamin B6 metabolism_Homo sapiens_hsa00750 | AOX1 | 1.2695 |